[
  {
    "survey_id": "3ebd1dfc-0f7b-4e5e-8746-48b2e80aff47",
    "hcp_id": "HCP_000000",
    "survey_date": "2025-01-15",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 5,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2024-12-28"
      },
      {
        "type": "detail",
        "date": "2024-12-24"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831100"
  },
  {
    "survey_id": "cc184b91-65e1-4a9f-baba-3e9aa4a15109",
    "hcp_id": "HCP_000000",
    "survey_date": "2025-01-15",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": -2,
    "awareness_score": 4,
    "favorability_score": 3,
    "previous_survey_id": "3ebd1dfc-0f7b-4e5e-8746-48b2e80aff47",
    "days_since_last_survey": 67,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-02"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831139"
  },
  {
    "survey_id": "06ab1ddb-ab4b-44e2-9f85-fa2ede2354d3",
    "hcp_id": "HCP_000000",
    "survey_date": "2025-01-15",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 2,
    "previous_survey_id": "cc184b91-65e1-4a9f-baba-3e9aa4a15109",
    "days_since_last_survey": 31,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2024-12-30"
      },
      {
        "type": "email",
        "date": "2024-12-20"
      },
      {
        "type": "webinar",
        "date": "2024-12-28"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831169"
  },
  {
    "survey_id": "94f29655-4444-4d33-932c-8ab37cb96c4b",
    "hcp_id": "HCP_000001",
    "survey_date": "2025-01-01",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 6,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2024-12-31"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831188"
  },
  {
    "survey_id": "a64a52e0-a4f6-4a8b-af20-5fa2d68180ac",
    "hcp_id": "HCP_000001",
    "survey_date": "2025-01-01",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 1,
    "awareness_score": 5,
    "favorability_score": 7,
    "previous_survey_id": "94f29655-4444-4d33-932c-8ab37cb96c4b",
    "days_since_last_survey": 57,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2024-12-28"
      },
      {
        "type": "sample",
        "date": "2024-12-10"
      },
      {
        "type": "detail",
        "date": "2024-12-09"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831207"
  },
  {
    "survey_id": "543a3cf3-0e70-4b6c-9109-83a54d0bfab7",
    "hcp_id": "HCP_000001",
    "survey_date": "2025-01-01",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -3,
    "awareness_score": 4,
    "favorability_score": 5,
    "previous_survey_id": "a64a52e0-a4f6-4a8b-af20-5fa2d68180ac",
    "days_since_last_survey": 60,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831222"
  },
  {
    "survey_id": "10933e49-8495-40db-88d8-10156441c665",
    "hcp_id": "HCP_000001",
    "survey_date": "2025-02-17",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 6,
    "awareness_score": 5,
    "favorability_score": 3,
    "previous_survey_id": "543a3cf3-0e70-4b6c-9109-83a54d0bfab7",
    "days_since_last_survey": 52,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-22"
      },
      {
        "type": "sample",
        "date": "2025-02-14"
      },
      {
        "type": "email",
        "date": "2025-01-28"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831260"
  },
  {
    "survey_id": "eaa71fd5-7e9f-4421-8898-7b0e5563afbf",
    "hcp_id": "HCP_000001",
    "survey_date": "2025-02-17",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 3,
    "favorability_score": 3,
    "previous_survey_id": "10933e49-8495-40db-88d8-10156441c665",
    "days_since_last_survey": 87,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-31"
      },
      {
        "type": "detail",
        "date": "2025-01-28"
      },
      {
        "type": "email",
        "date": "2025-01-23"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831300"
  },
  {
    "survey_id": "49eb21df-82cd-462b-bc56-3cafb1529d5d",
    "hcp_id": "HCP_000001",
    "survey_date": "2025-02-17",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -4,
    "awareness_score": 5,
    "favorability_score": 6,
    "previous_survey_id": "eaa71fd5-7e9f-4421-8898-7b0e5563afbf",
    "days_since_last_survey": 44,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-01"
      },
      {
        "type": "email",
        "date": "2025-01-22"
      },
      {
        "type": "sample",
        "date": "2025-01-25"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831326"
  },
  {
    "survey_id": "14c68d3b-58e4-4687-864b-62126c370358",
    "hcp_id": "HCP_000001",
    "survey_date": "2025-03-20",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 4,
    "awareness_score": 7,
    "favorability_score": 4,
    "previous_survey_id": "49eb21df-82cd-462b-bc56-3cafb1529d5d",
    "days_since_last_survey": 32,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-02-23"
      },
      {
        "type": "detail",
        "date": "2025-03-03"
      },
      {
        "type": "email",
        "date": "2025-02-18"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831355"
  },
  {
    "survey_id": "9e88a819-197a-49d2-9d28-033691f1e9a0",
    "hcp_id": "HCP_000001",
    "survey_date": "2025-03-20",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -4,
    "awareness_score": 6,
    "favorability_score": 5,
    "previous_survey_id": "14c68d3b-58e4-4687-864b-62126c370358",
    "days_since_last_survey": 41,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-02-27"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831374"
  },
  {
    "survey_id": "eeda6b53-5092-457e-9d21-b32a576ee5cc",
    "hcp_id": "HCP_000001",
    "survey_date": "2025-03-20",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -2,
    "awareness_score": 4,
    "favorability_score": 6,
    "previous_survey_id": "9e88a819-197a-49d2-9d28-033691f1e9a0",
    "days_since_last_survey": 42,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-03-19"
      },
      {
        "type": "webinar",
        "date": "2025-03-13"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831393"
  },
  {
    "survey_id": "328da693-9aa5-431a-861e-c6454a2794c8",
    "hcp_id": "HCP_000002",
    "survey_date": "2025-01-17",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 7,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831417"
  },
  {
    "survey_id": "1d7d67fc-5adf-48fb-a823-ed41acdcc6a4",
    "hcp_id": "HCP_000002",
    "survey_date": "2025-01-17",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 3,
    "awareness_score": 5,
    "favorability_score": 5,
    "previous_survey_id": "328da693-9aa5-431a-861e-c6454a2794c8",
    "days_since_last_survey": 60,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2024-12-29"
      },
      {
        "type": "detail",
        "date": "2025-01-07"
      },
      {
        "type": "email",
        "date": "2025-01-01"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.831453"
  },
  {
    "survey_id": "762c3335-f82b-4d59-a8e5-6161c261dbbf",
    "hcp_id": "HCP_000002",
    "survey_date": "2025-01-17",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 2,
    "awareness_score": 7,
    "favorability_score": 4,
    "previous_survey_id": "1d7d67fc-5adf-48fb-a823-ed41acdcc6a4",
    "days_since_last_survey": 40,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2024-12-19"
      },
      {
        "type": "sample",
        "date": "2024-12-22"
      },
      {
        "type": "detail",
        "date": "2025-01-13"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831484"
  },
  {
    "survey_id": "2a7ce497-418c-4213-8e49-fd3811f48ec9",
    "hcp_id": "HCP_000003",
    "survey_date": "2025-01-03",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 3,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831510"
  },
  {
    "survey_id": "0af96ddf-90f2-4b73-a2e0-b3ad08cd7942",
    "hcp_id": "HCP_000003",
    "survey_date": "2025-01-03",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -3,
    "awareness_score": 6,
    "favorability_score": 3,
    "previous_survey_id": "2a7ce497-418c-4213-8e49-fd3811f48ec9",
    "days_since_last_survey": 30,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2024-12-16"
      },
      {
        "type": "email",
        "date": "2024-12-29"
      },
      {
        "type": "webinar",
        "date": "2024-12-26"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831535"
  },
  {
    "survey_id": "5726b476-e816-405f-b375-86081cfff4e3",
    "hcp_id": "HCP_000003",
    "survey_date": "2025-01-03",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 1,
    "awareness_score": 3,
    "favorability_score": 6,
    "previous_survey_id": "0af96ddf-90f2-4b73-a2e0-b3ad08cd7942",
    "days_since_last_survey": 67,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2024-12-04"
      },
      {
        "type": "sample",
        "date": "2024-12-08"
      },
      {
        "type": "webinar",
        "date": "2024-12-05"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.831561"
  },
  {
    "survey_id": "ac7da8dc-9305-4787-8cee-7472e5cbaed3",
    "hcp_id": "HCP_000003",
    "survey_date": "2025-02-20",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 2,
    "awareness_score": 4,
    "favorability_score": 2,
    "previous_survey_id": "5726b476-e816-405f-b375-86081cfff4e3",
    "days_since_last_survey": 35,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-02-17"
      },
      {
        "type": "sample",
        "date": "2025-01-21"
      },
      {
        "type": "webinar",
        "date": "2025-02-06"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831589"
  },
  {
    "survey_id": "31f0b6ae-ed0b-4928-914b-2e10ffd591cb",
    "hcp_id": "HCP_000003",
    "survey_date": "2025-02-20",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -3,
    "awareness_score": 5,
    "favorability_score": 5,
    "previous_survey_id": "ac7da8dc-9305-4787-8cee-7472e5cbaed3",
    "days_since_last_survey": 59,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-31"
      },
      {
        "type": "webinar",
        "date": "2025-01-31"
      },
      {
        "type": "detail",
        "date": "2025-02-03"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831614"
  },
  {
    "survey_id": "59461dd1-971c-4b13-859b-ed6a74ccfb4a",
    "hcp_id": "HCP_000003",
    "survey_date": "2025-02-20",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 4,
    "awareness_score": 5,
    "favorability_score": 2,
    "previous_survey_id": "31f0b6ae-ed0b-4928-914b-2e10ffd591cb",
    "days_since_last_survey": 41,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831637"
  },
  {
    "survey_id": "6eb79c0b-a679-4dbe-a535-3404e5f3c7d9",
    "hcp_id": "HCP_000004",
    "survey_date": "2025-01-07",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 5,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2024-12-23"
      },
      {
        "type": "email",
        "date": "2024-12-29"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831657"
  },
  {
    "survey_id": "991b6071-2abb-40fc-924f-6144bdf947b1",
    "hcp_id": "HCP_000004",
    "survey_date": "2025-01-07",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -3,
    "awareness_score": 3,
    "favorability_score": 5,
    "previous_survey_id": "6eb79c0b-a679-4dbe-a535-3404e5f3c7d9",
    "days_since_last_survey": 62,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831673"
  },
  {
    "survey_id": "8799d091-2122-4178-9346-94bcae4ca5ff",
    "hcp_id": "HCP_000004",
    "survey_date": "2025-01-07",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 3,
    "awareness_score": 5,
    "favorability_score": 2,
    "previous_survey_id": "991b6071-2abb-40fc-924f-6144bdf947b1",
    "days_since_last_survey": 62,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-04"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831705"
  },
  {
    "survey_id": "9a274efb-c545-449b-a2cb-68a188f010e8",
    "hcp_id": "HCP_000004",
    "survey_date": "2025-02-07",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -3,
    "awareness_score": 3,
    "favorability_score": 5,
    "previous_survey_id": "8799d091-2122-4178-9346-94bcae4ca5ff",
    "days_since_last_survey": 79,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-01"
      },
      {
        "type": "sample",
        "date": "2025-01-24"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831734"
  },
  {
    "survey_id": "df69b9fc-e406-4490-9a4c-e6533ead062a",
    "hcp_id": "HCP_000004",
    "survey_date": "2025-02-07",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 1,
    "awareness_score": 5,
    "favorability_score": 6,
    "previous_survey_id": "9a274efb-c545-449b-a2cb-68a188f010e8",
    "days_since_last_survey": 84,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-16"
      },
      {
        "type": "email",
        "date": "2025-01-09"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831819"
  },
  {
    "survey_id": "d6b6c343-e8fe-4b14-983a-06f04e545d0f",
    "hcp_id": "HCP_000004",
    "survey_date": "2025-02-07",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 1,
    "awareness_score": 4,
    "favorability_score": 5,
    "previous_survey_id": "df69b9fc-e406-4490-9a4c-e6533ead062a",
    "days_since_last_survey": 81,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-10"
      },
      {
        "type": "sample",
        "date": "2025-01-18"
      },
      {
        "type": "sample",
        "date": "2025-02-02"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831860"
  },
  {
    "survey_id": "473b8573-bba3-4843-9866-5e079de0220a",
    "hcp_id": "HCP_000004",
    "survey_date": "2025-03-09",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 0,
    "awareness_score": 5,
    "favorability_score": 3,
    "previous_survey_id": "d6b6c343-e8fe-4b14-983a-06f04e545d0f",
    "days_since_last_survey": 33,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-02-08"
      },
      {
        "type": "webinar",
        "date": "2025-02-22"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.831887"
  },
  {
    "survey_id": "305b19fe-7579-406f-a595-2d4073705184",
    "hcp_id": "HCP_000004",
    "survey_date": "2025-03-09",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -1,
    "awareness_score": 5,
    "favorability_score": 3,
    "previous_survey_id": "473b8573-bba3-4843-9866-5e079de0220a",
    "days_since_last_survey": 70,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-03-01"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831902"
  },
  {
    "survey_id": "5d87f84b-dd36-4fb7-be06-54be57a62e8e",
    "hcp_id": "HCP_000004",
    "survey_date": "2025-03-09",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 2,
    "awareness_score": 6,
    "favorability_score": 6,
    "previous_survey_id": "305b19fe-7579-406f-a595-2d4073705184",
    "days_since_last_survey": 83,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-02-28"
      },
      {
        "type": "detail",
        "date": "2025-02-25"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831921"
  },
  {
    "survey_id": "f49b06ec-758f-4a71-ade1-63b876d83272",
    "hcp_id": "HCP_000005",
    "survey_date": "2025-01-25",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 0,
    "awareness_score": 5,
    "favorability_score": 6,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2024-12-27"
      },
      {
        "type": "detail",
        "date": "2024-12-31"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831954"
  },
  {
    "survey_id": "d1b1715f-a693-4f55-b87b-1f12e8b79d92",
    "hcp_id": "HCP_000005",
    "survey_date": "2025-01-25",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 4,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "f49b06ec-758f-4a71-ade1-63b876d83272",
    "days_since_last_survey": 47,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2024-12-29"
      },
      {
        "type": "sample",
        "date": "2025-01-07"
      },
      {
        "type": "email",
        "date": "2025-01-03"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831973"
  },
  {
    "survey_id": "8d144a13-0383-4414-8ece-b7d34afa5066",
    "hcp_id": "HCP_000005",
    "survey_date": "2025-01-25",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": -1,
    "awareness_score": 4,
    "favorability_score": 2,
    "previous_survey_id": "d1b1715f-a693-4f55-b87b-1f12e8b79d92",
    "days_since_last_survey": 39,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2024-12-31"
      },
      {
        "type": "detail",
        "date": "2025-01-06"
      },
      {
        "type": "webinar",
        "date": "2025-01-07"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.831995"
  },
  {
    "survey_id": "d0737646-4421-4ed5-ac94-51a8579cfcc9",
    "hcp_id": "HCP_000005",
    "survey_date": "2025-02-10",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -4,
    "awareness_score": 5,
    "favorability_score": 6,
    "previous_survey_id": "8d144a13-0383-4414-8ece-b7d34afa5066",
    "days_since_last_survey": 44,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-15"
      },
      {
        "type": "sample",
        "date": "2025-01-26"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832022"
  },
  {
    "survey_id": "b188bd7a-d31a-4a97-863e-8b3ca7bfa437",
    "hcp_id": "HCP_000005",
    "survey_date": "2025-02-10",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 1,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "d0737646-4421-4ed5-ac94-51a8579cfcc9",
    "days_since_last_survey": 81,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-16"
      },
      {
        "type": "detail",
        "date": "2025-01-11"
      },
      {
        "type": "detail",
        "date": "2025-01-26"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832040"
  },
  {
    "survey_id": "03edfe88-e7e5-4f9f-8afd-7ba9d01a16c2",
    "hcp_id": "HCP_000005",
    "survey_date": "2025-02-10",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -2,
    "awareness_score": 3,
    "favorability_score": 6,
    "previous_survey_id": "b188bd7a-d31a-4a97-863e-8b3ca7bfa437",
    "days_since_last_survey": 54,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-07"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832056"
  },
  {
    "survey_id": "3b0e173c-4acd-4c28-b614-ac3156d9d1de",
    "hcp_id": "HCP_000006",
    "survey_date": "2025-01-15",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 6,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832082"
  },
  {
    "survey_id": "62653cf6-d559-4abb-8540-de18f360e8d0",
    "hcp_id": "HCP_000006",
    "survey_date": "2025-01-15",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -1,
    "awareness_score": 5,
    "favorability_score": 5,
    "previous_survey_id": "3b0e173c-4acd-4c28-b614-ac3156d9d1de",
    "days_since_last_survey": 81,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832094"
  },
  {
    "survey_id": "b69e3dd4-d61c-4cb3-8a1e-9e5a653246a8",
    "hcp_id": "HCP_000006",
    "survey_date": "2025-01-15",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 4,
    "awareness_score": 5,
    "favorability_score": 2,
    "previous_survey_id": "62653cf6-d559-4abb-8540-de18f360e8d0",
    "days_since_last_survey": 69,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-07"
      },
      {
        "type": "detail",
        "date": "2024-12-28"
      },
      {
        "type": "email",
        "date": "2024-12-18"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832115"
  },
  {
    "survey_id": "9e3b7b74-9a1c-4cf8-b16f-98f99dfde4e1",
    "hcp_id": "HCP_000006",
    "survey_date": "2025-02-24",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 1,
    "awareness_score": 3,
    "favorability_score": 3,
    "previous_survey_id": "b69e3dd4-d61c-4cb3-8a1e-9e5a653246a8",
    "days_since_last_survey": 37,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-13"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832144"
  },
  {
    "survey_id": "d6e7b4b6-2885-46e2-859a-f886c3601949",
    "hcp_id": "HCP_000006",
    "survey_date": "2025-02-24",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": -3,
    "awareness_score": 4,
    "favorability_score": 2,
    "previous_survey_id": "9e3b7b74-9a1c-4cf8-b16f-98f99dfde4e1",
    "days_since_last_survey": 80,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-31"
      },
      {
        "type": "detail",
        "date": "2025-02-12"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832169"
  },
  {
    "survey_id": "1267e5d0-6e6d-4775-8e36-b6c7ec3ab91a",
    "hcp_id": "HCP_000006",
    "survey_date": "2025-02-24",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 3,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "d6e7b4b6-2885-46e2-859a-f886c3601949",
    "days_since_last_survey": 82,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-26"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832212"
  },
  {
    "survey_id": "d159a44a-35e6-439f-92c5-4cde2b928717",
    "hcp_id": "HCP_000006",
    "survey_date": "2025-03-21",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 3,
    "previous_survey_id": "1267e5d0-6e6d-4775-8e36-b6c7ec3ab91a",
    "days_since_last_survey": 39,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-03-03"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832238"
  },
  {
    "survey_id": "7758ca41-6743-471c-87ac-d3d642cdb665",
    "hcp_id": "HCP_000006",
    "survey_date": "2025-03-21",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": -3,
    "awareness_score": 5,
    "favorability_score": 2,
    "previous_survey_id": "d159a44a-35e6-439f-92c5-4cde2b928717",
    "days_since_last_survey": 68,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-03-16"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832270"
  },
  {
    "survey_id": "9165fd19-1714-4c6f-af1d-a555766bbd3e",
    "hcp_id": "HCP_000006",
    "survey_date": "2025-03-21",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -3,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "7758ca41-6743-471c-87ac-d3d642cdb665",
    "days_since_last_survey": 74,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-03-16"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832307"
  },
  {
    "survey_id": "4b9e7958-48a9-44ed-b6e0-7cb312a13b02",
    "hcp_id": "HCP_000007",
    "survey_date": "2025-01-01",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 4,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2024-12-17"
      },
      {
        "type": "email",
        "date": "2024-12-27"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832336"
  },
  {
    "survey_id": "4c9ee426-8978-41c9-9190-7e3aec6c13d8",
    "hcp_id": "HCP_000007",
    "survey_date": "2025-01-01",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 6,
    "awareness_score": 3,
    "favorability_score": 6,
    "previous_survey_id": "4b9e7958-48a9-44ed-b6e0-7cb312a13b02",
    "days_since_last_survey": 74,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2024-12-27"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832362"
  },
  {
    "survey_id": "47e5e0e8-ad6b-453c-909d-36235e951ba0",
    "hcp_id": "HCP_000007",
    "survey_date": "2025-01-01",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -5,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "4c9ee426-8978-41c9-9190-7e3aec6c13d8",
    "days_since_last_survey": 62,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832375"
  },
  {
    "survey_id": "c354ebf5-f3c2-4afb-a9ec-85225990acb1",
    "hcp_id": "HCP_000007",
    "survey_date": "2025-02-11",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 1,
    "awareness_score": 6,
    "favorability_score": 5,
    "previous_survey_id": "47e5e0e8-ad6b-453c-909d-36235e951ba0",
    "days_since_last_survey": 64,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832390"
  },
  {
    "survey_id": "db6295f8-131c-4642-ab39-9b266fc7e22a",
    "hcp_id": "HCP_000007",
    "survey_date": "2025-02-11",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 2,
    "awareness_score": 7,
    "favorability_score": 2,
    "previous_survey_id": "c354ebf5-f3c2-4afb-a9ec-85225990acb1",
    "days_since_last_survey": 58,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-15"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832404"
  },
  {
    "survey_id": "ca94776c-07d4-496c-97a5-c5835ae38fbe",
    "hcp_id": "HCP_000007",
    "survey_date": "2025-02-11",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 7,
    "previous_survey_id": "db6295f8-131c-4642-ab39-9b266fc7e22a",
    "days_since_last_survey": 58,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-16"
      },
      {
        "type": "detail",
        "date": "2025-02-06"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832420"
  },
  {
    "survey_id": "4ba5e77b-ea74-41b1-8cc0-81e2b7991d1b",
    "hcp_id": "HCP_000007",
    "survey_date": "2025-03-24",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -4,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "ca94776c-07d4-496c-97a5-c5835ae38fbe",
    "days_since_last_survey": 47,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-03-18"
      },
      {
        "type": "detail",
        "date": "2025-03-21"
      },
      {
        "type": "email",
        "date": "2025-03-16"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832456"
  },
  {
    "survey_id": "b22d6b08-8223-40d4-8bda-add3a9fd4f87",
    "hcp_id": "HCP_000007",
    "survey_date": "2025-03-24",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 4,
    "awareness_score": 7,
    "favorability_score": 7,
    "previous_survey_id": "4ba5e77b-ea74-41b1-8cc0-81e2b7991d1b",
    "days_since_last_survey": 53,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-03-11"
      },
      {
        "type": "sample",
        "date": "2025-02-25"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832473"
  },
  {
    "survey_id": "f40929c1-6a74-4089-a433-b0e29867fc3a",
    "hcp_id": "HCP_000007",
    "survey_date": "2025-03-24",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -2,
    "awareness_score": 3,
    "favorability_score": 6,
    "previous_survey_id": "b22d6b08-8223-40d4-8bda-add3a9fd4f87",
    "days_since_last_survey": 72,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-03-13"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.832496"
  },
  {
    "survey_id": "c33de81e-64bb-4dcd-98bb-94ec72f97286",
    "hcp_id": "HCP_000008",
    "survey_date": "2025-01-30",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 3,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-23"
      },
      {
        "type": "email",
        "date": "2024-12-31"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832543"
  },
  {
    "survey_id": "fb780b53-84c0-4267-b7df-040e560d2e87",
    "hcp_id": "HCP_000008",
    "survey_date": "2025-01-30",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 1,
    "awareness_score": 5,
    "favorability_score": 3,
    "previous_survey_id": "c33de81e-64bb-4dcd-98bb-94ec72f97286",
    "days_since_last_survey": 32,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832565"
  },
  {
    "survey_id": "1d60fb3c-1c09-4b72-b7e2-f34e410fb067",
    "hcp_id": "HCP_000008",
    "survey_date": "2025-01-30",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 1,
    "awareness_score": 7,
    "favorability_score": 7,
    "previous_survey_id": "fb780b53-84c0-4267-b7df-040e560d2e87",
    "days_since_last_survey": 55,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-13"
      },
      {
        "type": "webinar",
        "date": "2025-01-11"
      },
      {
        "type": "detail",
        "date": "2025-01-13"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832586"
  },
  {
    "survey_id": "a2263300-73fe-4559-ba52-d18a1f6062cb",
    "hcp_id": "HCP_000009",
    "survey_date": "2025-01-09",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 3,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2024-12-15"
      },
      {
        "type": "detail",
        "date": "2024-12-14"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832612"
  },
  {
    "survey_id": "e5c25e55-a4e2-49a9-89b4-16d1b99ba124",
    "hcp_id": "HCP_000009",
    "survey_date": "2025-01-09",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 3,
    "awareness_score": 5,
    "favorability_score": 7,
    "previous_survey_id": "a2263300-73fe-4559-ba52-d18a1f6062cb",
    "days_since_last_survey": 36,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832625"
  },
  {
    "survey_id": "db31fc7d-1b2f-46d6-ae51-bf4d7c6f54da",
    "hcp_id": "HCP_000009",
    "survey_date": "2025-01-09",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -3,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "e5c25e55-a4e2-49a9-89b4-16d1b99ba124",
    "days_since_last_survey": 33,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2024-12-31"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832640"
  },
  {
    "survey_id": "4a48bef9-55a7-4c19-af83-8896e8933e85",
    "hcp_id": "HCP_000010",
    "survey_date": "2025-01-26",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 6,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-02"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832656"
  },
  {
    "survey_id": "8174ae06-6d4e-4e91-9079-8c7ff1acd156",
    "hcp_id": "HCP_000010",
    "survey_date": "2025-01-26",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 4,
    "previous_survey_id": "4a48bef9-55a7-4c19-af83-8896e8933e85",
    "days_since_last_survey": 74,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-07"
      },
      {
        "type": "webinar",
        "date": "2025-01-01"
      },
      {
        "type": "email",
        "date": "2024-12-29"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832687"
  },
  {
    "survey_id": "5278e45b-74f4-40d6-afc1-711e70c20028",
    "hcp_id": "HCP_000010",
    "survey_date": "2025-01-26",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 3,
    "awareness_score": 5,
    "favorability_score": 3,
    "previous_survey_id": "8174ae06-6d4e-4e91-9079-8c7ff1acd156",
    "days_since_last_survey": 68,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-12"
      },
      {
        "type": "webinar",
        "date": "2025-01-17"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832720"
  },
  {
    "survey_id": "d69ca746-93ce-4410-8711-df93d7fc7953",
    "hcp_id": "HCP_000010",
    "survey_date": "2025-02-18",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 7,
    "previous_survey_id": "5278e45b-74f4-40d6-afc1-711e70c20028",
    "days_since_last_survey": 60,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-30"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.832747"
  },
  {
    "survey_id": "4a6f95d0-fc09-4e19-be6b-14554ca99961",
    "hcp_id": "HCP_000010",
    "survey_date": "2025-02-18",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -3,
    "awareness_score": 6,
    "favorability_score": 4,
    "previous_survey_id": "d69ca746-93ce-4410-8711-df93d7fc7953",
    "days_since_last_survey": 78,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-02-03"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832783"
  },
  {
    "survey_id": "8b96af38-2a3f-45da-805f-3e955d223e80",
    "hcp_id": "HCP_000010",
    "survey_date": "2025-02-18",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 4,
    "awareness_score": 5,
    "favorability_score": 5,
    "previous_survey_id": "4a6f95d0-fc09-4e19-be6b-14554ca99961",
    "days_since_last_survey": 59,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-22"
      },
      {
        "type": "webinar",
        "date": "2025-01-28"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832810"
  },
  {
    "survey_id": "bed54456-7589-462a-8ca1-4959a72f9a50",
    "hcp_id": "HCP_000011",
    "survey_date": "2025-01-05",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": 0,
    "awareness_score": 3,
    "favorability_score": 6,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2024-12-08"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.832839"
  },
  {
    "survey_id": "3364e234-f621-4c5a-a2ec-bce888123779",
    "hcp_id": "HCP_000011",
    "survey_date": "2025-01-05",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": 0,
    "awareness_score": 3,
    "favorability_score": 3,
    "previous_survey_id": "bed54456-7589-462a-8ca1-4959a72f9a50",
    "days_since_last_survey": 70,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2024-12-06"
      },
      {
        "type": "email",
        "date": "2024-12-14"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.832856"
  },
  {
    "survey_id": "3fcf6644-66d7-4203-b42d-b9ac67612ba3",
    "hcp_id": "HCP_000011",
    "survey_date": "2025-01-05",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 5,
    "awareness_score": 3,
    "favorability_score": 7,
    "previous_survey_id": "3364e234-f621-4c5a-a2ec-bce888123779",
    "days_since_last_survey": 32,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2024-12-10"
      },
      {
        "type": "email",
        "date": "2024-12-24"
      },
      {
        "type": "sample",
        "date": "2025-01-02"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832874"
  },
  {
    "survey_id": "3d667014-2ad3-4b4c-8efa-3a84d5dd916d",
    "hcp_id": "HCP_000011",
    "survey_date": "2025-02-08",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -4,
    "awareness_score": 5,
    "favorability_score": 3,
    "previous_survey_id": "3fcf6644-66d7-4203-b42d-b9ac67612ba3",
    "days_since_last_survey": 59,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832897"
  },
  {
    "survey_id": "0bae5afd-9e80-489d-a463-69fb4577e05c",
    "hcp_id": "HCP_000011",
    "survey_date": "2025-02-08",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 1,
    "awareness_score": 7,
    "favorability_score": 3,
    "previous_survey_id": "3d667014-2ad3-4b4c-8efa-3a84d5dd916d",
    "days_since_last_survey": 43,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-02-04"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832912"
  },
  {
    "survey_id": "6c9f7b45-c025-4320-ae6e-6fffbe2bec0e",
    "hcp_id": "HCP_000011",
    "survey_date": "2025-02-08",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 4,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "0bae5afd-9e80-489d-a463-69fb4577e05c",
    "days_since_last_survey": 89,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-25"
      },
      {
        "type": "sample",
        "date": "2025-01-30"
      },
      {
        "type": "email",
        "date": "2025-01-10"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832940"
  },
  {
    "survey_id": "2ef51f6b-300f-421e-a7e3-ae8779a762f5",
    "hcp_id": "HCP_000012",
    "survey_date": "2025-01-31",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 5,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-20"
      },
      {
        "type": "detail",
        "date": "2025-01-06"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.832973"
  },
  {
    "survey_id": "01cdb6a0-24d7-4b29-8fe5-2808a1cb7432",
    "hcp_id": "HCP_000012",
    "survey_date": "2025-01-31",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 7,
    "previous_survey_id": "2ef51f6b-300f-421e-a7e3-ae8779a762f5",
    "days_since_last_survey": 57,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-25"
      },
      {
        "type": "detail",
        "date": "2025-01-18"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.832989"
  },
  {
    "survey_id": "fddb9b70-5871-4eb7-b551-f5c8795c20b3",
    "hcp_id": "HCP_000012",
    "survey_date": "2025-01-31",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 1,
    "awareness_score": 5,
    "favorability_score": 5,
    "previous_survey_id": "01cdb6a0-24d7-4b29-8fe5-2808a1cb7432",
    "days_since_last_survey": 69,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-29"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833004"
  },
  {
    "survey_id": "93ca31ab-766d-45b1-ae28-8ae8cf2bb8ad",
    "hcp_id": "HCP_000012",
    "survey_date": "2025-02-24",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 0,
    "awareness_score": 5,
    "favorability_score": 4,
    "previous_survey_id": "fddb9b70-5871-4eb7-b551-f5c8795c20b3",
    "days_since_last_survey": 39,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.833031"
  },
  {
    "survey_id": "4cbf65b8-801f-4be4-afcf-6387169d555d",
    "hcp_id": "HCP_000012",
    "survey_date": "2025-02-24",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": -2,
    "awareness_score": 5,
    "favorability_score": 7,
    "previous_survey_id": "93ca31ab-766d-45b1-ae28-8ae8cf2bb8ad",
    "days_since_last_survey": 53,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-29"
      },
      {
        "type": "sample",
        "date": "2025-02-23"
      },
      {
        "type": "sample",
        "date": "2025-02-07"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833055"
  },
  {
    "survey_id": "1845295b-62ed-494f-ab90-51930a628413",
    "hcp_id": "HCP_000012",
    "survey_date": "2025-02-24",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 2,
    "awareness_score": 5,
    "favorability_score": 7,
    "previous_survey_id": "4cbf65b8-801f-4be4-afcf-6387169d555d",
    "days_since_last_survey": 35,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-29"
      },
      {
        "type": "detail",
        "date": "2025-01-27"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833081"
  },
  {
    "survey_id": "521e3f46-5bac-4b80-80b9-024a356bc382",
    "hcp_id": "HCP_000012",
    "survey_date": "2025-03-14",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -5,
    "awareness_score": 6,
    "favorability_score": 6,
    "previous_survey_id": "1845295b-62ed-494f-ab90-51930a628413",
    "days_since_last_survey": 41,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-02-14"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833099"
  },
  {
    "survey_id": "d5dfaf11-2ef4-4920-8692-d2b46339c2f6",
    "hcp_id": "HCP_000012",
    "survey_date": "2025-03-14",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 6,
    "awareness_score": 5,
    "favorability_score": 7,
    "previous_survey_id": "521e3f46-5bac-4b80-80b9-024a356bc382",
    "days_since_last_survey": 33,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-03-10"
      },
      {
        "type": "detail",
        "date": "2025-02-25"
      },
      {
        "type": "sample",
        "date": "2025-02-20"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833118"
  },
  {
    "survey_id": "f3b67e4b-04c5-4b6b-bc15-0b4d9e8d215c",
    "hcp_id": "HCP_000012",
    "survey_date": "2025-03-14",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -4,
    "awareness_score": 6,
    "favorability_score": 3,
    "previous_survey_id": "d5dfaf11-2ef4-4920-8692-d2b46339c2f6",
    "days_since_last_survey": 88,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-02-17"
      },
      {
        "type": "detail",
        "date": "2025-03-10"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833134"
  },
  {
    "survey_id": "8189029c-4c0b-44fd-802c-5dfa3915405c",
    "hcp_id": "HCP_000013",
    "survey_date": "2025-01-06",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 0,
    "awareness_score": 3,
    "favorability_score": 4,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833153"
  },
  {
    "survey_id": "a39f2443-300f-48f7-b90e-c36f7b03e972",
    "hcp_id": "HCP_000013",
    "survey_date": "2025-01-06",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -3,
    "awareness_score": 6,
    "favorability_score": 2,
    "previous_survey_id": "8189029c-4c0b-44fd-802c-5dfa3915405c",
    "days_since_last_survey": 79,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833168"
  },
  {
    "survey_id": "50a082a2-cdb5-40e0-8ee6-9dd270f233b7",
    "hcp_id": "HCP_000013",
    "survey_date": "2025-01-06",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 4,
    "awareness_score": 4,
    "favorability_score": 3,
    "previous_survey_id": "a39f2443-300f-48f7-b90e-c36f7b03e972",
    "days_since_last_survey": 56,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-01"
      },
      {
        "type": "detail",
        "date": "2024-12-10"
      },
      {
        "type": "webinar",
        "date": "2024-12-24"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833197"
  },
  {
    "survey_id": "d8ab5273-e1c0-4c15-8b47-2840f92b17ff",
    "hcp_id": "HCP_000014",
    "survey_date": "2025-01-29",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 7,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833222"
  },
  {
    "survey_id": "1f4d768a-0e1f-444d-94d3-adf90d7f035a",
    "hcp_id": "HCP_000014",
    "survey_date": "2025-01-29",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 1,
    "awareness_score": 6,
    "favorability_score": 6,
    "previous_survey_id": "d8ab5273-e1c0-4c15-8b47-2840f92b17ff",
    "days_since_last_survey": 31,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-21"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.833243"
  },
  {
    "survey_id": "84e40404-5968-428a-962f-887acb5ec87c",
    "hcp_id": "HCP_000014",
    "survey_date": "2025-01-29",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 2,
    "previous_survey_id": "1f4d768a-0e1f-444d-94d3-adf90d7f035a",
    "days_since_last_survey": 83,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-02"
      },
      {
        "type": "sample",
        "date": "2025-01-24"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833289"
  },
  {
    "survey_id": "df76bcf7-5d5b-4306-b7ec-33302c3cfaa7",
    "hcp_id": "HCP_000014",
    "survey_date": "2025-02-07",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": -1,
    "awareness_score": 6,
    "favorability_score": 7,
    "previous_survey_id": "84e40404-5968-428a-962f-887acb5ec87c",
    "days_since_last_survey": 85,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-25"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833315"
  },
  {
    "survey_id": "36970938-8174-4d88-805a-852d83f64b7e",
    "hcp_id": "HCP_000014",
    "survey_date": "2025-02-07",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -4,
    "awareness_score": 4,
    "favorability_score": 5,
    "previous_survey_id": "df76bcf7-5d5b-4306-b7ec-33302c3cfaa7",
    "days_since_last_survey": 68,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-28"
      },
      {
        "type": "detail",
        "date": "2025-01-17"
      },
      {
        "type": "sample",
        "date": "2025-01-12"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833333"
  },
  {
    "survey_id": "590b536d-6ce2-40ee-b5e3-3e78c554ec8a",
    "hcp_id": "HCP_000014",
    "survey_date": "2025-02-07",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 3,
    "awareness_score": 6,
    "favorability_score": 7,
    "previous_survey_id": "36970938-8174-4d88-805a-852d83f64b7e",
    "days_since_last_survey": 53,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833351"
  },
  {
    "survey_id": "d89aacee-4842-482c-ae8e-d3c105152400",
    "hcp_id": "HCP_000015",
    "survey_date": "2025-01-25",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 4,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-18"
      },
      {
        "type": "detail",
        "date": "2025-01-10"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833380"
  },
  {
    "survey_id": "9b74af6d-c77a-4889-b542-03bf420eff88",
    "hcp_id": "HCP_000015",
    "survey_date": "2025-01-25",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -3,
    "awareness_score": 7,
    "favorability_score": 2,
    "previous_survey_id": "d89aacee-4842-482c-ae8e-d3c105152400",
    "days_since_last_survey": 53,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833393"
  },
  {
    "survey_id": "08b43db4-bcdc-4a95-bcd2-734a51ddfa7a",
    "hcp_id": "HCP_000015",
    "survey_date": "2025-01-25",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 4,
    "previous_survey_id": "9b74af6d-c77a-4889-b542-03bf420eff88",
    "days_since_last_survey": 71,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-05"
      },
      {
        "type": "email",
        "date": "2025-01-01"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833409"
  },
  {
    "survey_id": "71aa63c5-cc2a-487a-96dd-fcacd084db67",
    "hcp_id": "HCP_000015",
    "survey_date": "2025-02-16",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 4,
    "awareness_score": 4,
    "favorability_score": 6,
    "previous_survey_id": "08b43db4-bcdc-4a95-bcd2-734a51ddfa7a",
    "days_since_last_survey": 31,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-21"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833440"
  },
  {
    "survey_id": "c999de73-e075-47a1-b6c0-133b6a7c4f4d",
    "hcp_id": "HCP_000015",
    "survey_date": "2025-02-16",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 7,
    "previous_survey_id": "71aa63c5-cc2a-487a-96dd-fcacd084db67",
    "days_since_last_survey": 82,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-01"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833458"
  },
  {
    "survey_id": "a950fc3b-af40-4be7-88a6-cfe38a441149",
    "hcp_id": "HCP_000015",
    "survey_date": "2025-02-16",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": -1,
    "awareness_score": 5,
    "favorability_score": 2,
    "previous_survey_id": "c999de73-e075-47a1-b6c0-133b6a7c4f4d",
    "days_since_last_survey": 37,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-02-01"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833473"
  },
  {
    "survey_id": "1276fc4d-f0ec-407f-95e8-1204774f5121",
    "hcp_id": "HCP_000015",
    "survey_date": "2025-03-26",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 4,
    "previous_survey_id": "a950fc3b-af40-4be7-88a6-cfe38a441149",
    "days_since_last_survey": 34,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-03-05"
      },
      {
        "type": "email",
        "date": "2025-03-12"
      },
      {
        "type": "detail",
        "date": "2025-02-28"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833512"
  },
  {
    "survey_id": "c0192079-3d1f-4d0b-8d6e-83cb36ddbd54",
    "hcp_id": "HCP_000015",
    "survey_date": "2025-03-26",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -3,
    "awareness_score": 4,
    "favorability_score": 6,
    "previous_survey_id": "1276fc4d-f0ec-407f-95e8-1204774f5121",
    "days_since_last_survey": 65,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833533"
  },
  {
    "survey_id": "66d95a57-df4d-4125-81a6-7912421a683a",
    "hcp_id": "HCP_000015",
    "survey_date": "2025-03-26",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -1,
    "awareness_score": 3,
    "favorability_score": 5,
    "previous_survey_id": "c0192079-3d1f-4d0b-8d6e-83cb36ddbd54",
    "days_since_last_survey": 77,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-02-27"
      },
      {
        "type": "email",
        "date": "2025-02-27"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.833552"
  },
  {
    "survey_id": "fafbe906-3c65-4315-af2d-da2e81549924",
    "hcp_id": "HCP_000016",
    "survey_date": "2025-01-24",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 0,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2024-12-29"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.833577"
  },
  {
    "survey_id": "d1de0bf3-af72-4c18-a758-e0a67525da86",
    "hcp_id": "HCP_000016",
    "survey_date": "2025-01-24",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": -1,
    "awareness_score": 5,
    "favorability_score": 6,
    "previous_survey_id": "fafbe906-3c65-4315-af2d-da2e81549924",
    "days_since_last_survey": 71,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-03"
      },
      {
        "type": "email",
        "date": "2025-01-18"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833594"
  },
  {
    "survey_id": "2c200ebe-2372-41f9-b6f9-be323ea53361",
    "hcp_id": "HCP_000016",
    "survey_date": "2025-01-24",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 7,
    "previous_survey_id": "d1de0bf3-af72-4c18-a758-e0a67525da86",
    "days_since_last_survey": 38,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-07"
      },
      {
        "type": "sample",
        "date": "2025-01-13"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833610"
  },
  {
    "survey_id": "7fcd6deb-55a6-4375-8064-baac6a04ec22",
    "hcp_id": "HCP_000017",
    "survey_date": "2025-01-20",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 5,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-07"
      },
      {
        "type": "sample",
        "date": "2025-01-03"
      },
      {
        "type": "webinar",
        "date": "2025-01-10"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833631"
  },
  {
    "survey_id": "491d17dd-07eb-4dd8-9f70-90d2e7b12918",
    "hcp_id": "HCP_000017",
    "survey_date": "2025-01-20",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -3,
    "awareness_score": 5,
    "favorability_score": 3,
    "previous_survey_id": "7fcd6deb-55a6-4375-8064-baac6a04ec22",
    "days_since_last_survey": 74,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833647"
  },
  {
    "survey_id": "2d795488-50dc-40b9-ab18-7a9de422aa48",
    "hcp_id": "HCP_000017",
    "survey_date": "2025-01-20",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 2,
    "awareness_score": 6,
    "favorability_score": 5,
    "previous_survey_id": "491d17dd-07eb-4dd8-9f70-90d2e7b12918",
    "days_since_last_survey": 66,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2024-12-30"
      },
      {
        "type": "webinar",
        "date": "2025-01-16"
      },
      {
        "type": "detail",
        "date": "2025-01-18"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833667"
  },
  {
    "survey_id": "7f0ba236-3b91-4d36-a1fb-453557705128",
    "hcp_id": "HCP_000017",
    "survey_date": "2025-02-16",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -4,
    "awareness_score": 5,
    "favorability_score": 6,
    "previous_survey_id": "2d795488-50dc-40b9-ab18-7a9de422aa48",
    "days_since_last_survey": 40,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-29"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833693"
  },
  {
    "survey_id": "42064928-a4c3-4fa4-b199-b8eed3a96eec",
    "hcp_id": "HCP_000017",
    "survey_date": "2025-02-16",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 3,
    "awareness_score": 4,
    "favorability_score": 2,
    "previous_survey_id": "7f0ba236-3b91-4d36-a1fb-453557705128",
    "days_since_last_survey": 69,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-02-14"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833711"
  },
  {
    "survey_id": "6b98a396-8ba9-4af4-b1b4-36e834e73493",
    "hcp_id": "HCP_000017",
    "survey_date": "2025-02-16",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 3,
    "awareness_score": 4,
    "favorability_score": 6,
    "previous_survey_id": "42064928-a4c3-4fa4-b199-b8eed3a96eec",
    "days_since_last_survey": 84,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-18"
      },
      {
        "type": "detail",
        "date": "2025-01-24"
      },
      {
        "type": "email",
        "date": "2025-01-23"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833730"
  },
  {
    "survey_id": "ab137f2f-cb43-484d-9dd2-52ca68229a4c",
    "hcp_id": "HCP_000017",
    "survey_date": "2025-03-05",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -5,
    "awareness_score": 7,
    "favorability_score": 3,
    "previous_survey_id": "6b98a396-8ba9-4af4-b1b4-36e834e73493",
    "days_since_last_survey": 74,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833752"
  },
  {
    "survey_id": "babd6d8b-5e32-470c-b625-f4ff43f3067c",
    "hcp_id": "HCP_000017",
    "survey_date": "2025-03-05",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 5,
    "awareness_score": 5,
    "favorability_score": 2,
    "previous_survey_id": "ab137f2f-cb43-484d-9dd2-52ca68229a4c",
    "days_since_last_survey": 90,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-09"
      },
      {
        "type": "webinar",
        "date": "2025-02-16"
      },
      {
        "type": "detail",
        "date": "2025-02-06"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833771"
  },
  {
    "survey_id": "1d3cb408-5786-43f2-9ce4-61e69d793ef9",
    "hcp_id": "HCP_000017",
    "survey_date": "2025-03-05",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": -2,
    "awareness_score": 5,
    "favorability_score": 6,
    "previous_survey_id": "babd6d8b-5e32-470c-b625-f4ff43f3067c",
    "days_since_last_survey": 43,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-02-08"
      },
      {
        "type": "email",
        "date": "2025-02-23"
      },
      {
        "type": "detail",
        "date": "2025-03-04"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833790"
  },
  {
    "survey_id": "62a70a9b-5261-41c8-99b3-9d07266b4d65",
    "hcp_id": "HCP_000018",
    "survey_date": "2025-01-27",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 5,
    "favorability_score": 2,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-03"
      },
      {
        "type": "sample",
        "date": "2025-01-19"
      },
      {
        "type": "webinar",
        "date": "2025-01-13"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.833817"
  },
  {
    "survey_id": "9ebebae6-5bec-4112-86c1-29adfc9049de",
    "hcp_id": "HCP_000018",
    "survey_date": "2025-01-27",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 6,
    "previous_survey_id": "62a70a9b-5261-41c8-99b3-9d07266b4d65",
    "days_since_last_survey": 31,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833846"
  },
  {
    "survey_id": "bd0ec87c-9765-4c39-bceb-7e764bb3dd3b",
    "hcp_id": "HCP_000018",
    "survey_date": "2025-01-27",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": -2,
    "awareness_score": 4,
    "favorability_score": 2,
    "previous_survey_id": "9ebebae6-5bec-4112-86c1-29adfc9049de",
    "days_since_last_survey": 82,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-13"
      },
      {
        "type": "webinar",
        "date": "2025-01-23"
      },
      {
        "type": "email",
        "date": "2025-01-19"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833890"
  },
  {
    "survey_id": "09203247-921d-453c-95b3-997284d59f55",
    "hcp_id": "HCP_000019",
    "survey_date": "2025-01-03",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 2,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2024-12-31"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833935"
  },
  {
    "survey_id": "48f0fabb-59ec-4e50-9649-39f00936f0df",
    "hcp_id": "HCP_000019",
    "survey_date": "2025-01-03",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -1,
    "awareness_score": 3,
    "favorability_score": 6,
    "previous_survey_id": "09203247-921d-453c-95b3-997284d59f55",
    "days_since_last_survey": 31,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2024-12-05"
      },
      {
        "type": "webinar",
        "date": "2024-12-15"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833965"
  },
  {
    "survey_id": "1ef70194-c6ea-481f-a4fc-1f92097c3221",
    "hcp_id": "HCP_000019",
    "survey_date": "2025-01-03",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 4,
    "awareness_score": 7,
    "favorability_score": 4,
    "previous_survey_id": "48f0fabb-59ec-4e50-9649-39f00936f0df",
    "days_since_last_survey": 84,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.833992"
  },
  {
    "survey_id": "dc8eff22-4fe2-481e-96af-7785c61378ff",
    "hcp_id": "HCP_000019",
    "survey_date": "2025-02-23",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 1,
    "awareness_score": 6,
    "favorability_score": 7,
    "previous_survey_id": "1ef70194-c6ea-481f-a4fc-1f92097c3221",
    "days_since_last_survey": 37,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834008"
  },
  {
    "survey_id": "31ab1035-6cb5-4ba4-8de9-9ed8e568b52f",
    "hcp_id": "HCP_000019",
    "survey_date": "2025-02-23",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -4,
    "awareness_score": 3,
    "favorability_score": 7,
    "previous_survey_id": "dc8eff22-4fe2-481e-96af-7785c61378ff",
    "days_since_last_survey": 42,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-30"
      },
      {
        "type": "sample",
        "date": "2025-02-22"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834024"
  },
  {
    "survey_id": "384d7ea2-5844-4685-9610-f4be8582d2dd",
    "hcp_id": "HCP_000019",
    "survey_date": "2025-02-23",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 5,
    "awareness_score": 6,
    "favorability_score": 6,
    "previous_survey_id": "31ab1035-6cb5-4ba4-8de9-9ed8e568b52f",
    "days_since_last_survey": 73,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-30"
      },
      {
        "type": "email",
        "date": "2025-02-22"
      },
      {
        "type": "sample",
        "date": "2025-02-12"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834042"
  },
  {
    "survey_id": "fee3f2b3-0642-4d81-ad27-784277ff91e9",
    "hcp_id": "HCP_000019",
    "survey_date": "2025-03-20",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -5,
    "awareness_score": 4,
    "favorability_score": 7,
    "previous_survey_id": "384d7ea2-5844-4685-9610-f4be8582d2dd",
    "days_since_last_survey": 39,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-03-18"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.834072"
  },
  {
    "survey_id": "4a46501d-5fde-4396-af52-01ce49aa3975",
    "hcp_id": "HCP_000019",
    "survey_date": "2025-03-20",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 3,
    "awareness_score": 6,
    "favorability_score": 3,
    "previous_survey_id": "fee3f2b3-0642-4d81-ad27-784277ff91e9",
    "days_since_last_survey": 40,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-27"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834086"
  },
  {
    "survey_id": "06ec4d0f-310c-496c-a454-108d76ac20be",
    "hcp_id": "HCP_000019",
    "survey_date": "2025-03-20",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -4,
    "awareness_score": 6,
    "favorability_score": 7,
    "previous_survey_id": "4a46501d-5fde-4396-af52-01ce49aa3975",
    "days_since_last_survey": 44,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834099"
  },
  {
    "survey_id": "b2b16df0-469c-47bb-91f0-d133c1b6e9d4",
    "hcp_id": "HCP_000020",
    "survey_date": "2025-01-14",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 5,
    "favorability_score": 6,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834115"
  },
  {
    "survey_id": "2dc418b3-a86b-43b8-8dad-6e1825715d55",
    "hcp_id": "HCP_000020",
    "survey_date": "2025-01-14",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -4,
    "awareness_score": 5,
    "favorability_score": 5,
    "previous_survey_id": "b2b16df0-469c-47bb-91f0-d133c1b6e9d4",
    "days_since_last_survey": 50,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2024-12-29"
      },
      {
        "type": "sample",
        "date": "2024-12-18"
      },
      {
        "type": "detail",
        "date": "2025-01-13"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834133"
  },
  {
    "survey_id": "5cb4335a-cf0a-4401-ad41-b1ef7c91f9dc",
    "hcp_id": "HCP_000020",
    "survey_date": "2025-01-14",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 4,
    "awareness_score": 4,
    "favorability_score": 7,
    "previous_survey_id": "2dc418b3-a86b-43b8-8dad-6e1825715d55",
    "days_since_last_survey": 61,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2024-12-15"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834161"
  },
  {
    "survey_id": "5bd6a674-955d-453b-8e9b-e4b66190c154",
    "hcp_id": "HCP_000020",
    "survey_date": "2025-02-02",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 6,
    "previous_survey_id": "5cb4335a-cf0a-4401-ad41-b1ef7c91f9dc",
    "days_since_last_survey": 61,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-23"
      },
      {
        "type": "webinar",
        "date": "2025-01-12"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834190"
  },
  {
    "survey_id": "093eef55-a987-4b39-a77a-bce239f76eb2",
    "hcp_id": "HCP_000020",
    "survey_date": "2025-02-02",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": -2,
    "awareness_score": 5,
    "favorability_score": 3,
    "previous_survey_id": "5bd6a674-955d-453b-8e9b-e4b66190c154",
    "days_since_last_survey": 68,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-17"
      },
      {
        "type": "email",
        "date": "2025-01-17"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834207"
  },
  {
    "survey_id": "52395667-385e-484d-9ecf-4beeb68b7ac0",
    "hcp_id": "HCP_000020",
    "survey_date": "2025-02-02",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 6,
    "previous_survey_id": "093eef55-a987-4b39-a77a-bce239f76eb2",
    "days_since_last_survey": 66,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-20"
      },
      {
        "type": "webinar",
        "date": "2025-01-11"
      },
      {
        "type": "detail",
        "date": "2025-01-17"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834225"
  },
  {
    "survey_id": "1fe4baa4-4859-451d-b33a-8d055e3fe968",
    "hcp_id": "HCP_000020",
    "survey_date": "2025-03-20",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": -1,
    "awareness_score": 4,
    "favorability_score": 5,
    "previous_survey_id": "52395667-385e-484d-9ecf-4beeb68b7ac0",
    "days_since_last_survey": 48,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-03-09"
      },
      {
        "type": "email",
        "date": "2025-02-28"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834271"
  },
  {
    "survey_id": "26d98611-2eb9-4908-b47d-6d5b9135a7cb",
    "hcp_id": "HCP_000020",
    "survey_date": "2025-03-20",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -3,
    "awareness_score": 5,
    "favorability_score": 7,
    "previous_survey_id": "1fe4baa4-4859-451d-b33a-8d055e3fe968",
    "days_since_last_survey": 38,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834295"
  },
  {
    "survey_id": "234bda49-88bb-4d1a-bb44-c34ed7ebbea3",
    "hcp_id": "HCP_000020",
    "survey_date": "2025-03-20",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": 0,
    "awareness_score": 5,
    "favorability_score": 6,
    "previous_survey_id": "26d98611-2eb9-4908-b47d-6d5b9135a7cb",
    "days_since_last_survey": 60,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-03-19"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.834310"
  },
  {
    "survey_id": "958b584a-da35-45dc-a29a-d20ac88b5b6f",
    "hcp_id": "HCP_000020",
    "survey_date": "2025-04-26",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 4,
    "awareness_score": 6,
    "favorability_score": 7,
    "previous_survey_id": "234bda49-88bb-4d1a-bb44-c34ed7ebbea3",
    "days_since_last_survey": 81,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834337"
  },
  {
    "survey_id": "affebbb7-8144-4386-8750-ec42daa2e589",
    "hcp_id": "HCP_000020",
    "survey_date": "2025-04-26",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -2,
    "awareness_score": 3,
    "favorability_score": 7,
    "previous_survey_id": "958b584a-da35-45dc-a29a-d20ac88b5b6f",
    "days_since_last_survey": 69,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-04-20"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834369"
  },
  {
    "survey_id": "312a5154-1d77-47e3-a93a-0d237f8c9ae2",
    "hcp_id": "HCP_000020",
    "survey_date": "2025-04-26",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -2,
    "awareness_score": 3,
    "favorability_score": 4,
    "previous_survey_id": "affebbb7-8144-4386-8750-ec42daa2e589",
    "days_since_last_survey": 76,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834397"
  },
  {
    "survey_id": "e70a622a-e5d8-4b0c-b58a-8fc0a783b988",
    "hcp_id": "HCP_000021",
    "survey_date": "2025-01-14",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 3,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834427"
  },
  {
    "survey_id": "20ec1185-67b4-4e95-a44e-c05366985afa",
    "hcp_id": "HCP_000021",
    "survey_date": "2025-01-14",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -1,
    "awareness_score": 4,
    "favorability_score": 6,
    "previous_survey_id": "e70a622a-e5d8-4b0c-b58a-8fc0a783b988",
    "days_since_last_survey": 51,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2024-12-19"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834462"
  },
  {
    "survey_id": "563e2f36-b2e1-44eb-9b6d-b7653c5d084f",
    "hcp_id": "HCP_000021",
    "survey_date": "2025-01-14",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 4,
    "awareness_score": 5,
    "favorability_score": 2,
    "previous_survey_id": "20ec1185-67b4-4e95-a44e-c05366985afa",
    "days_since_last_survey": 65,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834479"
  },
  {
    "survey_id": "6d742969-a7b6-4143-bd53-502ea8fe84aa",
    "hcp_id": "HCP_000021",
    "survey_date": "2025-01-31",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 0,
    "awareness_score": 5,
    "favorability_score": 2,
    "previous_survey_id": "563e2f36-b2e1-44eb-9b6d-b7653c5d084f",
    "days_since_last_survey": 84,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834497"
  },
  {
    "survey_id": "c8836914-ba0b-4280-9b36-2857d98be7ce",
    "hcp_id": "HCP_000021",
    "survey_date": "2025-01-31",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -3,
    "awareness_score": 7,
    "favorability_score": 7,
    "previous_survey_id": "6d742969-a7b6-4143-bd53-502ea8fe84aa",
    "days_since_last_survey": 45,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-04"
      },
      {
        "type": "detail",
        "date": "2025-01-20"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834515"
  },
  {
    "survey_id": "6c01d9c3-5fb9-4fa9-997d-1cdb892fcf28",
    "hcp_id": "HCP_000021",
    "survey_date": "2025-01-31",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 1,
    "awareness_score": 6,
    "favorability_score": 2,
    "previous_survey_id": "c8836914-ba0b-4280-9b36-2857d98be7ce",
    "days_since_last_survey": 37,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-19"
      },
      {
        "type": "webinar",
        "date": "2025-01-02"
      },
      {
        "type": "webinar",
        "date": "2025-01-16"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834536"
  },
  {
    "survey_id": "4af4cae4-d9ab-4c0e-b78e-63c681a061c9",
    "hcp_id": "HCP_000021",
    "survey_date": "2025-03-29",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 1,
    "awareness_score": 5,
    "favorability_score": 5,
    "previous_survey_id": "6c01d9c3-5fb9-4fa9-997d-1cdb892fcf28",
    "days_since_last_survey": 72,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-03-16"
      },
      {
        "type": "email",
        "date": "2025-03-18"
      },
      {
        "type": "sample",
        "date": "2025-03-15"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834566"
  },
  {
    "survey_id": "07bc0197-f0e0-448a-8a08-ffdac7864cb7",
    "hcp_id": "HCP_000021",
    "survey_date": "2025-03-29",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -2,
    "awareness_score": 4,
    "favorability_score": 5,
    "previous_survey_id": "4af4cae4-d9ab-4c0e-b78e-63c681a061c9",
    "days_since_last_survey": 56,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834581"
  },
  {
    "survey_id": "cdafba1f-538c-4da7-bf47-019833d0456e",
    "hcp_id": "HCP_000021",
    "survey_date": "2025-03-29",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -1,
    "awareness_score": 3,
    "favorability_score": 6,
    "previous_survey_id": "07bc0197-f0e0-448a-8a08-ffdac7864cb7",
    "days_since_last_survey": 30,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-03-24"
      },
      {
        "type": "detail",
        "date": "2025-03-21"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834598"
  },
  {
    "survey_id": "39e81e38-5e1e-4115-a289-7c028b486a4e",
    "hcp_id": "HCP_000021",
    "survey_date": "2025-04-20",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 3,
    "awareness_score": 6,
    "favorability_score": 7,
    "previous_survey_id": "cdafba1f-538c-4da7-bf47-019833d0456e",
    "days_since_last_survey": 55,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-04-13"
      },
      {
        "type": "sample",
        "date": "2025-04-04"
      },
      {
        "type": "sample",
        "date": "2025-04-10"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834619"
  },
  {
    "survey_id": "b4f46f3c-9fb1-4390-8e7a-fdd869d1ad7c",
    "hcp_id": "HCP_000021",
    "survey_date": "2025-04-20",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -2,
    "awareness_score": 3,
    "favorability_score": 7,
    "previous_survey_id": "39e81e38-5e1e-4115-a289-7c028b486a4e",
    "days_since_last_survey": 80,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-04-12"
      },
      {
        "type": "detail",
        "date": "2025-04-08"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834636"
  },
  {
    "survey_id": "659d8162-f2f2-4eae-83eb-b9edbada7b50",
    "hcp_id": "HCP_000021",
    "survey_date": "2025-04-20",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 2,
    "previous_survey_id": "b4f46f3c-9fb1-4390-8e7a-fdd869d1ad7c",
    "days_since_last_survey": 78,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834652"
  },
  {
    "survey_id": "1f13c451-c7c2-476a-aee6-4573353488fd",
    "hcp_id": "HCP_000022",
    "survey_date": "2025-01-15",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 5,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2024-12-30"
      },
      {
        "type": "email",
        "date": "2025-01-08"
      },
      {
        "type": "detail",
        "date": "2024-12-16"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834677"
  },
  {
    "survey_id": "7ceda662-7179-492b-b7d9-0028ca11527b",
    "hcp_id": "HCP_000022",
    "survey_date": "2025-01-15",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -2,
    "awareness_score": 5,
    "favorability_score": 5,
    "previous_survey_id": "1f13c451-c7c2-476a-aee6-4573353488fd",
    "days_since_last_survey": 48,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2024-12-16"
      },
      {
        "type": "email",
        "date": "2024-12-25"
      },
      {
        "type": "email",
        "date": "2025-01-06"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834709"
  },
  {
    "survey_id": "9cedc90b-c2aa-4204-8739-f3ae02c22aa8",
    "hcp_id": "HCP_000022",
    "survey_date": "2025-01-15",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 3,
    "previous_survey_id": "7ceda662-7179-492b-b7d9-0028ca11527b",
    "days_since_last_survey": 72,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2024-12-16"
      },
      {
        "type": "sample",
        "date": "2024-12-21"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834734"
  },
  {
    "survey_id": "b81044e6-6581-4714-9854-53e1f8129270",
    "hcp_id": "HCP_000023",
    "survey_date": "2025-01-19",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 7,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-16"
      },
      {
        "type": "webinar",
        "date": "2024-12-20"
      },
      {
        "type": "webinar",
        "date": "2025-01-09"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834767"
  },
  {
    "survey_id": "b15b9409-901e-4afc-8d87-2f1901f14734",
    "hcp_id": "HCP_000023",
    "survey_date": "2025-01-19",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 6,
    "previous_survey_id": "b81044e6-6581-4714-9854-53e1f8129270",
    "days_since_last_survey": 52,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-06"
      },
      {
        "type": "email",
        "date": "2025-01-14"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834784"
  },
  {
    "survey_id": "87ef723f-9b68-4011-817b-8146a93f3b48",
    "hcp_id": "HCP_000023",
    "survey_date": "2025-01-19",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -2,
    "awareness_score": 5,
    "favorability_score": 3,
    "previous_survey_id": "b15b9409-901e-4afc-8d87-2f1901f14734",
    "days_since_last_survey": 58,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-04"
      },
      {
        "type": "webinar",
        "date": "2024-12-27"
      },
      {
        "type": "sample",
        "date": "2025-01-05"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834802"
  },
  {
    "survey_id": "781fae38-3c5d-4808-ba29-136f85de9713",
    "hcp_id": "HCP_000023",
    "survey_date": "2025-03-02",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 2,
    "awareness_score": 3,
    "favorability_score": 3,
    "previous_survey_id": "87ef723f-9b68-4011-817b-8146a93f3b48",
    "days_since_last_survey": 65,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834827"
  },
  {
    "survey_id": "552948bd-bdd5-4816-b401-54418d8c6238",
    "hcp_id": "HCP_000023",
    "survey_date": "2025-03-02",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -1,
    "awareness_score": 3,
    "favorability_score": 5,
    "previous_survey_id": "781fae38-3c5d-4808-ba29-136f85de9713",
    "days_since_last_survey": 79,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-02-26"
      },
      {
        "type": "webinar",
        "date": "2025-02-11"
      },
      {
        "type": "detail",
        "date": "2025-02-26"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.834845"
  },
  {
    "survey_id": "1d9158a7-1037-4c94-895c-112686649b85",
    "hcp_id": "HCP_000023",
    "survey_date": "2025-03-02",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 2,
    "previous_survey_id": "552948bd-bdd5-4816-b401-54418d8c6238",
    "days_since_last_survey": 72,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-02-19"
      },
      {
        "type": "email",
        "date": "2025-03-01"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834865"
  },
  {
    "survey_id": "6f5a15e1-6296-4f45-834a-86f0519a766f",
    "hcp_id": "HCP_000023",
    "survey_date": "2025-03-31",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 4,
    "awareness_score": 4,
    "favorability_score": 7,
    "previous_survey_id": "1d9158a7-1037-4c94-895c-112686649b85",
    "days_since_last_survey": 89,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-03-11"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834899"
  },
  {
    "survey_id": "352e24e4-abfc-44b4-ae37-5157135ede8b",
    "hcp_id": "HCP_000023",
    "survey_date": "2025-03-31",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -4,
    "awareness_score": 6,
    "favorability_score": 7,
    "previous_survey_id": "6f5a15e1-6296-4f45-834a-86f0519a766f",
    "days_since_last_survey": 46,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-03-01"
      },
      {
        "type": "detail",
        "date": "2025-03-01"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834916"
  },
  {
    "survey_id": "ccf67593-6e79-455d-a724-1e95cf68534f",
    "hcp_id": "HCP_000023",
    "survey_date": "2025-03-31",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -1,
    "awareness_score": 7,
    "favorability_score": 7,
    "previous_survey_id": "352e24e4-abfc-44b4-ae37-5157135ede8b",
    "days_since_last_survey": 48,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-03-12"
      },
      {
        "type": "email",
        "date": "2025-03-03"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834950"
  },
  {
    "survey_id": "50641c9b-42a0-4e39-984e-5c4867ccad38",
    "hcp_id": "HCP_000023",
    "survey_date": "2025-04-08",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 3,
    "awareness_score": 3,
    "favorability_score": 4,
    "previous_survey_id": "ccf67593-6e79-455d-a724-1e95cf68534f",
    "days_since_last_survey": 31,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-04-01"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.834992"
  },
  {
    "survey_id": "91a7c01f-f6cd-496a-a3ae-6179c566f90a",
    "hcp_id": "HCP_000023",
    "survey_date": "2025-04-08",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -3,
    "awareness_score": 5,
    "favorability_score": 2,
    "previous_survey_id": "50641c9b-42a0-4e39-984e-5c4867ccad38",
    "days_since_last_survey": 71,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-03-21"
      },
      {
        "type": "email",
        "date": "2025-03-15"
      },
      {
        "type": "webinar",
        "date": "2025-03-22"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835011"
  },
  {
    "survey_id": "ac586382-13fd-4601-98a4-6222c2f4af39",
    "hcp_id": "HCP_000023",
    "survey_date": "2025-04-08",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 3,
    "awareness_score": 3,
    "favorability_score": 5,
    "previous_survey_id": "91a7c01f-f6cd-496a-a3ae-6179c566f90a",
    "days_since_last_survey": 68,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-03-28"
      },
      {
        "type": "sample",
        "date": "2025-03-19"
      },
      {
        "type": "webinar",
        "date": "2025-03-14"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835030"
  },
  {
    "survey_id": "62bbc2f0-52de-4087-8f46-0fe10b12682a",
    "hcp_id": "HCP_000024",
    "survey_date": "2025-01-06",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 5,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2024-12-15"
      },
      {
        "type": "detail",
        "date": "2024-12-19"
      },
      {
        "type": "sample",
        "date": "2024-12-08"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835060"
  },
  {
    "survey_id": "38d46943-870d-41ff-a969-14d551a0e9e5",
    "hcp_id": "HCP_000024",
    "survey_date": "2025-01-06",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 3,
    "awareness_score": 5,
    "favorability_score": 3,
    "previous_survey_id": "62bbc2f0-52de-4087-8f46-0fe10b12682a",
    "days_since_last_survey": 60,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-02"
      },
      {
        "type": "email",
        "date": "2024-12-19"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835077"
  },
  {
    "survey_id": "0dfe32e6-ed8b-49df-a537-581650bd7a7b",
    "hcp_id": "HCP_000024",
    "survey_date": "2025-01-06",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 2,
    "awareness_score": 6,
    "favorability_score": 4,
    "previous_survey_id": "38d46943-870d-41ff-a969-14d551a0e9e5",
    "days_since_last_survey": 58,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835089"
  },
  {
    "survey_id": "940b9f1d-93d8-419e-af80-4fcba1437c05",
    "hcp_id": "HCP_000024",
    "survey_date": "2025-02-28",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": -2,
    "awareness_score": 6,
    "favorability_score": 4,
    "previous_survey_id": "0dfe32e6-ed8b-49df-a537-581650bd7a7b",
    "days_since_last_survey": 50,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-25"
      },
      {
        "type": "detail",
        "date": "2025-02-09"
      },
      {
        "type": "webinar",
        "date": "2025-02-15"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835114"
  },
  {
    "survey_id": "ced552d5-8927-48fa-b757-606f2643308f",
    "hcp_id": "HCP_000024",
    "survey_date": "2025-02-28",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 1,
    "awareness_score": 4,
    "favorability_score": 4,
    "previous_survey_id": "940b9f1d-93d8-419e-af80-4fcba1437c05",
    "days_since_last_survey": 82,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-02-06"
      },
      {
        "type": "email",
        "date": "2025-02-08"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835146"
  },
  {
    "survey_id": "e4e70049-e6fa-4da3-a446-a5a623d92e2d",
    "hcp_id": "HCP_000024",
    "survey_date": "2025-02-28",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -2,
    "awareness_score": 7,
    "favorability_score": 5,
    "previous_survey_id": "ced552d5-8927-48fa-b757-606f2643308f",
    "days_since_last_survey": 76,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-30"
      },
      {
        "type": "email",
        "date": "2025-02-11"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835172"
  },
  {
    "survey_id": "ec35cd52-dec5-4b02-9c15-f06fb5b315b3",
    "hcp_id": "HCP_000024",
    "survey_date": "2025-03-15",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -2,
    "awareness_score": 5,
    "favorability_score": 6,
    "previous_survey_id": "e4e70049-e6fa-4da3-a446-a5a623d92e2d",
    "days_since_last_survey": 31,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-03-05"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835197"
  },
  {
    "survey_id": "13e05deb-100f-4b5c-98a1-63995af4dc23",
    "hcp_id": "HCP_000024",
    "survey_date": "2025-03-15",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 2,
    "awareness_score": 5,
    "favorability_score": 5,
    "previous_survey_id": "ec35cd52-dec5-4b02-9c15-f06fb5b315b3",
    "days_since_last_survey": 33,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835210"
  },
  {
    "survey_id": "ac4e5a34-ee5e-4c25-9362-41d96f8ef0fa",
    "hcp_id": "HCP_000024",
    "survey_date": "2025-03-15",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 3,
    "awareness_score": 5,
    "favorability_score": 5,
    "previous_survey_id": "13e05deb-100f-4b5c-98a1-63995af4dc23",
    "days_since_last_survey": 45,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-27"
      },
      {
        "type": "webinar",
        "date": "2025-03-02"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835226"
  },
  {
    "survey_id": "91b68433-b491-44fb-8e89-920210f9e14b",
    "hcp_id": "HCP_000025",
    "survey_date": "2025-01-22",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 4,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2024-12-23"
      },
      {
        "type": "email",
        "date": "2024-12-30"
      },
      {
        "type": "webinar",
        "date": "2025-01-15"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835248"
  },
  {
    "survey_id": "9a8809cb-8b2d-47a9-9904-d11184668c15",
    "hcp_id": "HCP_000025",
    "survey_date": "2025-01-22",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": -2,
    "awareness_score": 5,
    "favorability_score": 2,
    "previous_survey_id": "91b68433-b491-44fb-8e89-920210f9e14b",
    "days_since_last_survey": 65,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.835277"
  },
  {
    "survey_id": "0a5d83f8-e188-445f-a1f3-7f54b24a6904",
    "hcp_id": "HCP_000025",
    "survey_date": "2025-01-22",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -1,
    "awareness_score": 6,
    "favorability_score": 4,
    "previous_survey_id": "9a8809cb-8b2d-47a9-9904-d11184668c15",
    "days_since_last_survey": 58,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835291"
  },
  {
    "survey_id": "7abf6092-6320-49e0-b363-7a1ef5e5ba54",
    "hcp_id": "HCP_000025",
    "survey_date": "2025-02-07",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -1,
    "awareness_score": 4,
    "favorability_score": 4,
    "previous_survey_id": "0a5d83f8-e188-445f-a1f3-7f54b24a6904",
    "days_since_last_survey": 73,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-28"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835310"
  },
  {
    "survey_id": "5b5af5ae-fab4-4cd7-8a58-5b47e22e413e",
    "hcp_id": "HCP_000025",
    "survey_date": "2025-02-07",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 4,
    "awareness_score": 6,
    "favorability_score": 2,
    "previous_survey_id": "7abf6092-6320-49e0-b363-7a1ef5e5ba54",
    "days_since_last_survey": 60,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835322"
  },
  {
    "survey_id": "148832ee-2645-475e-ad9e-c146a27d4359",
    "hcp_id": "HCP_000025",
    "survey_date": "2025-02-07",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -4,
    "awareness_score": 7,
    "favorability_score": 7,
    "previous_survey_id": "5b5af5ae-fab4-4cd7-8a58-5b47e22e413e",
    "days_since_last_survey": 87,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-02-05"
      },
      {
        "type": "email",
        "date": "2025-01-17"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835347"
  },
  {
    "survey_id": "eaf4bf78-58ee-4150-97fb-f8253a72994c",
    "hcp_id": "HCP_000026",
    "survey_date": "2025-01-30",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-18"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835375"
  },
  {
    "survey_id": "d5a610d4-4e64-4eb7-a2e1-501b40dfedf6",
    "hcp_id": "HCP_000026",
    "survey_date": "2025-01-30",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -4,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "eaf4bf78-58ee-4150-97fb-f8253a72994c",
    "days_since_last_survey": 80,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835388"
  },
  {
    "survey_id": "23f7ca7d-ccf4-4b4a-a2fa-84e4a1795a2b",
    "hcp_id": "HCP_000026",
    "survey_date": "2025-01-30",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -1,
    "awareness_score": 3,
    "favorability_score": 3,
    "previous_survey_id": "d5a610d4-4e64-4eb7-a2e1-501b40dfedf6",
    "days_since_last_survey": 60,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-06"
      },
      {
        "type": "webinar",
        "date": "2025-01-28"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835404"
  },
  {
    "survey_id": "933fb8ff-0379-47f9-95bd-fba7e3b7cd5f",
    "hcp_id": "HCP_000026",
    "survey_date": "2025-02-08",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 3,
    "awareness_score": 4,
    "favorability_score": 2,
    "previous_survey_id": "23f7ca7d-ccf4-4b4a-a2fa-84e4a1795a2b",
    "days_since_last_survey": 83,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-16"
      },
      {
        "type": "email",
        "date": "2025-02-03"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835492"
  },
  {
    "survey_id": "b83b4c9e-5b98-4b92-9dd7-93dd89fbd270",
    "hcp_id": "HCP_000026",
    "survey_date": "2025-02-08",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 2,
    "awareness_score": 5,
    "favorability_score": 7,
    "previous_survey_id": "933fb8ff-0379-47f9-95bd-fba7e3b7cd5f",
    "days_since_last_survey": 84,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-17"
      },
      {
        "type": "sample",
        "date": "2025-02-05"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835518"
  },
  {
    "survey_id": "192b6a78-e508-4a52-8d3c-6770f35b4525",
    "hcp_id": "HCP_000026",
    "survey_date": "2025-02-08",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -4,
    "awareness_score": 7,
    "favorability_score": 2,
    "previous_survey_id": "b83b4c9e-5b98-4b92-9dd7-93dd89fbd270",
    "days_since_last_survey": 87,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-02-07"
      },
      {
        "type": "sample",
        "date": "2025-01-28"
      },
      {
        "type": "email",
        "date": "2025-01-10"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835536"
  },
  {
    "survey_id": "7e54bdcc-06b7-474d-95cc-1a0044b9f132",
    "hcp_id": "HCP_000027",
    "survey_date": "2025-01-22",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 6,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2024-12-24"
      },
      {
        "type": "email",
        "date": "2024-12-25"
      },
      {
        "type": "webinar",
        "date": "2024-12-25"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835565"
  },
  {
    "survey_id": "45301e9d-cf86-4a79-95d1-28374fff5bcc",
    "hcp_id": "HCP_000027",
    "survey_date": "2025-01-22",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -4,
    "awareness_score": 6,
    "favorability_score": 3,
    "previous_survey_id": "7e54bdcc-06b7-474d-95cc-1a0044b9f132",
    "days_since_last_survey": 44,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-11"
      },
      {
        "type": "email",
        "date": "2025-01-18"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835590"
  },
  {
    "survey_id": "752cfb7f-c4e0-4f17-9634-e49d97162d9e",
    "hcp_id": "HCP_000027",
    "survey_date": "2025-01-22",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 2,
    "awareness_score": 3,
    "favorability_score": 5,
    "previous_survey_id": "45301e9d-cf86-4a79-95d1-28374fff5bcc",
    "days_since_last_survey": 79,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-07"
      },
      {
        "type": "webinar",
        "date": "2025-01-18"
      },
      {
        "type": "sample",
        "date": "2025-01-18"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835611"
  },
  {
    "survey_id": "a2fa4940-ae56-4e1d-b8a4-47288412822e",
    "hcp_id": "HCP_000027",
    "survey_date": "2025-02-13",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -3,
    "awareness_score": 4,
    "favorability_score": 5,
    "previous_survey_id": "752cfb7f-c4e0-4f17-9634-e49d97162d9e",
    "days_since_last_survey": 83,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835640"
  },
  {
    "survey_id": "218a0b5a-050b-4514-8934-ca190d7e4bdf",
    "hcp_id": "HCP_000027",
    "survey_date": "2025-02-13",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -1,
    "awareness_score": 4,
    "favorability_score": 2,
    "previous_survey_id": "a2fa4940-ae56-4e1d-b8a4-47288412822e",
    "days_since_last_survey": 36,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-23"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835655"
  },
  {
    "survey_id": "49eb608c-ff30-49d5-8543-c37dd83bd004",
    "hcp_id": "HCP_000027",
    "survey_date": "2025-02-13",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 7,
    "previous_survey_id": "218a0b5a-050b-4514-8934-ca190d7e4bdf",
    "days_since_last_survey": 55,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835668"
  },
  {
    "survey_id": "c23e0d0d-4ef9-4569-b495-29d793610062",
    "hcp_id": "HCP_000027",
    "survey_date": "2025-03-02",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 3,
    "awareness_score": 3,
    "favorability_score": 6,
    "previous_survey_id": "49eb608c-ff30-49d5-8543-c37dd83bd004",
    "days_since_last_survey": 56,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835685"
  },
  {
    "survey_id": "b36417bb-d19b-4042-a7c7-d05745c7e66a",
    "hcp_id": "HCP_000027",
    "survey_date": "2025-03-02",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 2,
    "awareness_score": 7,
    "favorability_score": 5,
    "previous_survey_id": "c23e0d0d-4ef9-4569-b495-29d793610062",
    "days_since_last_survey": 64,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835698"
  },
  {
    "survey_id": "3c9f88ad-5f0d-4540-a315-f998533a35a6",
    "hcp_id": "HCP_000027",
    "survey_date": "2025-03-02",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 1,
    "awareness_score": 7,
    "favorability_score": 3,
    "previous_survey_id": "b36417bb-d19b-4042-a7c7-d05745c7e66a",
    "days_since_last_survey": 61,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-02-16"
      },
      {
        "type": "detail",
        "date": "2025-02-02"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835720"
  },
  {
    "survey_id": "35929031-9cb1-488d-89e6-e5126ddf26a1",
    "hcp_id": "HCP_000027",
    "survey_date": "2025-04-05",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -6,
    "awareness_score": 4,
    "favorability_score": 5,
    "previous_survey_id": "3c9f88ad-5f0d-4540-a315-f998533a35a6",
    "days_since_last_survey": 50,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-03-11"
      },
      {
        "type": "sample",
        "date": "2025-03-06"
      },
      {
        "type": "email",
        "date": "2025-03-18"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835749"
  },
  {
    "survey_id": "638b8bde-c79f-476c-b217-7961c597ec17",
    "hcp_id": "HCP_000027",
    "survey_date": "2025-04-05",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 5,
    "previous_survey_id": "35929031-9cb1-488d-89e6-e5126ddf26a1",
    "days_since_last_survey": 82,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-03-31"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835770"
  },
  {
    "survey_id": "708f120d-81e8-4fec-b924-eb5d9c7a166a",
    "hcp_id": "HCP_000027",
    "survey_date": "2025-04-05",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 3,
    "awareness_score": 6,
    "favorability_score": 3,
    "previous_survey_id": "638b8bde-c79f-476c-b217-7961c597ec17",
    "days_since_last_survey": 30,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835783"
  },
  {
    "survey_id": "c35495f9-f74e-4497-bb43-246617b180e3",
    "hcp_id": "HCP_000028",
    "survey_date": "2025-01-04",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 3,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2024-12-25"
      },
      {
        "type": "webinar",
        "date": "2024-12-07"
      },
      {
        "type": "detail",
        "date": "2024-12-12"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835805"
  },
  {
    "survey_id": "b7a048b3-5c3a-4cce-b388-5f4887cc50eb",
    "hcp_id": "HCP_000028",
    "survey_date": "2025-01-04",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 0,
    "awareness_score": 5,
    "favorability_score": 3,
    "previous_survey_id": "c35495f9-f74e-4497-bb43-246617b180e3",
    "days_since_last_survey": 88,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2024-12-27"
      },
      {
        "type": "detail",
        "date": "2025-01-03"
      },
      {
        "type": "sample",
        "date": "2024-12-29"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835834"
  },
  {
    "survey_id": "b0cc04ea-8662-4cf7-89ec-142e6715e74f",
    "hcp_id": "HCP_000028",
    "survey_date": "2025-01-04",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -5,
    "awareness_score": 4,
    "favorability_score": 5,
    "previous_survey_id": "b7a048b3-5c3a-4cce-b388-5f4887cc50eb",
    "days_since_last_survey": 61,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835849"
  },
  {
    "survey_id": "2d08b93a-61a9-4a6e-9694-6ca993b31553",
    "hcp_id": "HCP_000028",
    "survey_date": "2025-02-21",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 6,
    "previous_survey_id": "b0cc04ea-8662-4cf7-89ec-142e6715e74f",
    "days_since_last_survey": 48,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-26"
      },
      {
        "type": "sample",
        "date": "2025-02-19"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835871"
  },
  {
    "survey_id": "580b699d-ce01-48e1-aeb4-5d3532353798",
    "hcp_id": "HCP_000028",
    "survey_date": "2025-02-21",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 6,
    "awareness_score": 3,
    "favorability_score": 6,
    "previous_survey_id": "2d08b93a-61a9-4a6e-9694-6ca993b31553",
    "days_since_last_survey": 63,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-02-19"
      },
      {
        "type": "email",
        "date": "2025-01-26"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835888"
  },
  {
    "survey_id": "3d772f7c-d9b5-41ec-8130-e091b41871a2",
    "hcp_id": "HCP_000028",
    "survey_date": "2025-02-21",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -4,
    "awareness_score": 5,
    "favorability_score": 2,
    "previous_survey_id": "580b699d-ce01-48e1-aeb4-5d3532353798",
    "days_since_last_survey": 46,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-02-16"
      },
      {
        "type": "webinar",
        "date": "2025-02-06"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.835908"
  },
  {
    "survey_id": "8f0b8256-3e11-4085-82dc-7101bc56a45d",
    "hcp_id": "HCP_000028",
    "survey_date": "2025-03-28",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 4,
    "awareness_score": 6,
    "favorability_score": 5,
    "previous_survey_id": "3d772f7c-d9b5-41ec-8130-e091b41871a2",
    "days_since_last_survey": 84,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-03-11"
      },
      {
        "type": "email",
        "date": "2025-03-08"
      },
      {
        "type": "email",
        "date": "2025-03-04"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835941"
  },
  {
    "survey_id": "47ad676b-167d-456c-8fd6-1f35d70df3b9",
    "hcp_id": "HCP_000028",
    "survey_date": "2025-03-28",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": -3,
    "awareness_score": 3,
    "favorability_score": 3,
    "previous_survey_id": "8f0b8256-3e11-4085-82dc-7101bc56a45d",
    "days_since_last_survey": 55,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-03-04"
      },
      {
        "type": "email",
        "date": "2025-03-10"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835966"
  },
  {
    "survey_id": "3083e1a1-244d-4d51-961a-6dc7fccc5cae",
    "hcp_id": "HCP_000028",
    "survey_date": "2025-03-28",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 7,
    "previous_survey_id": "47ad676b-167d-456c-8fd6-1f35d70df3b9",
    "days_since_last_survey": 53,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835978"
  },
  {
    "survey_id": "eedd73e7-8889-4799-a9d0-18e1b34ab5a8",
    "hcp_id": "HCP_000028",
    "survey_date": "2025-04-14",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -2,
    "awareness_score": 6,
    "favorability_score": 3,
    "previous_survey_id": "3083e1a1-244d-4d51-961a-6dc7fccc5cae",
    "days_since_last_survey": 87,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.835993"
  },
  {
    "survey_id": "a634b33d-a67b-464b-8ac2-209687582af3",
    "hcp_id": "HCP_000028",
    "survey_date": "2025-04-14",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 1,
    "awareness_score": 6,
    "favorability_score": 4,
    "previous_survey_id": "eedd73e7-8889-4799-a9d0-18e1b34ab5a8",
    "days_since_last_survey": 68,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-04-04"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836011"
  },
  {
    "survey_id": "ab8feb59-921b-49b0-89c7-857f4e685097",
    "hcp_id": "HCP_000028",
    "survey_date": "2025-04-14",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -2,
    "awareness_score": 4,
    "favorability_score": 7,
    "previous_survey_id": "a634b33d-a67b-464b-8ac2-209687582af3",
    "days_since_last_survey": 67,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-03-16"
      },
      {
        "type": "detail",
        "date": "2025-04-12"
      },
      {
        "type": "email",
        "date": "2025-03-19"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836049"
  },
  {
    "survey_id": "3acbb64d-3619-4881-915d-d3346dffa82f",
    "hcp_id": "HCP_000029",
    "survey_date": "2025-01-20",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 7,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-18"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836076"
  },
  {
    "survey_id": "e30e69b0-e1ca-4937-994f-5e61f425d671",
    "hcp_id": "HCP_000029",
    "survey_date": "2025-01-20",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": -1,
    "awareness_score": 6,
    "favorability_score": 3,
    "previous_survey_id": "3acbb64d-3619-4881-915d-d3346dffa82f",
    "days_since_last_survey": 58,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-08"
      },
      {
        "type": "sample",
        "date": "2024-12-27"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836096"
  },
  {
    "survey_id": "ccbdc334-0a1c-4903-a83a-cad5a6f6309d",
    "hcp_id": "HCP_000029",
    "survey_date": "2025-01-20",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -4,
    "awareness_score": 7,
    "favorability_score": 4,
    "previous_survey_id": "e30e69b0-e1ca-4937-994f-5e61f425d671",
    "days_since_last_survey": 33,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836118"
  },
  {
    "survey_id": "d30aabf7-b6f3-4366-8d6f-3c730631cba3",
    "hcp_id": "HCP_000029",
    "survey_date": "2025-03-02",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 6,
    "awareness_score": 4,
    "favorability_score": 3,
    "previous_survey_id": "ccbdc334-0a1c-4903-a83a-cad5a6f6309d",
    "days_since_last_survey": 82,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-02-13"
      },
      {
        "type": "detail",
        "date": "2025-02-28"
      },
      {
        "type": "detail",
        "date": "2025-02-03"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836140"
  },
  {
    "survey_id": "b35f3613-f66e-4a5f-afb1-802d7bbc9a90",
    "hcp_id": "HCP_000029",
    "survey_date": "2025-03-02",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -4,
    "awareness_score": 5,
    "favorability_score": 7,
    "previous_survey_id": "d30aabf7-b6f3-4366-8d6f-3c730631cba3",
    "days_since_last_survey": 89,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-02-28"
      },
      {
        "type": "webinar",
        "date": "2025-02-22"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836165"
  },
  {
    "survey_id": "806f5ea5-4df5-4b7c-a640-b5d2cad744ce",
    "hcp_id": "HCP_000029",
    "survey_date": "2025-03-02",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 3,
    "awareness_score": 3,
    "favorability_score": 5,
    "previous_survey_id": "b35f3613-f66e-4a5f-afb1-802d7bbc9a90",
    "days_since_last_survey": 63,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-02-20"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836180"
  },
  {
    "survey_id": "c00c19b1-4a7e-4576-923b-e1fd40c2b4db",
    "hcp_id": "HCP_000030",
    "survey_date": "2025-01-12",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 5,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836196"
  },
  {
    "survey_id": "44380929-f48e-4a35-a82a-0597cf291c23",
    "hcp_id": "HCP_000030",
    "survey_date": "2025-01-12",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -5,
    "awareness_score": 4,
    "favorability_score": 6,
    "previous_survey_id": "c00c19b1-4a7e-4576-923b-e1fd40c2b4db",
    "days_since_last_survey": 54,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-10"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836211"
  },
  {
    "survey_id": "33d54be7-2eb2-4feb-99bc-9069981a54fd",
    "hcp_id": "HCP_000030",
    "survey_date": "2025-01-12",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 6,
    "previous_survey_id": "44380929-f48e-4a35-a82a-0597cf291c23",
    "days_since_last_survey": 39,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2024-12-31"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836226"
  },
  {
    "survey_id": "55c69a7e-cc0f-4681-b420-289f4b7bebb7",
    "hcp_id": "HCP_000031",
    "survey_date": "2025-01-16",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 6,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836269"
  },
  {
    "survey_id": "a8ef0151-f60b-40ba-a14e-19ce1b95f49e",
    "hcp_id": "HCP_000031",
    "survey_date": "2025-01-16",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 5,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "55c69a7e-cc0f-4681-b420-289f4b7bebb7",
    "days_since_last_survey": 66,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-11"
      },
      {
        "type": "sample",
        "date": "2025-01-03"
      },
      {
        "type": "webinar",
        "date": "2024-12-27"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836306"
  },
  {
    "survey_id": "9c36d6c3-c6dd-426b-b0db-d813fa418aee",
    "hcp_id": "HCP_000031",
    "survey_date": "2025-01-16",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": -1,
    "awareness_score": 4,
    "favorability_score": 2,
    "previous_survey_id": "a8ef0151-f60b-40ba-a14e-19ce1b95f49e",
    "days_since_last_survey": 45,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836327"
  },
  {
    "survey_id": "e0f436af-b78c-45cb-9f4e-ef4b2a5eb0f9",
    "hcp_id": "HCP_000031",
    "survey_date": "2025-02-14",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 1,
    "awareness_score": 7,
    "favorability_score": 3,
    "previous_survey_id": "9c36d6c3-c6dd-426b-b0db-d813fa418aee",
    "days_since_last_survey": 32,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-26"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836344"
  },
  {
    "survey_id": "c2284360-61f6-4689-a35f-cf0d55019436",
    "hcp_id": "HCP_000031",
    "survey_date": "2025-02-14",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": -1,
    "awareness_score": 5,
    "favorability_score": 4,
    "previous_survey_id": "e0f436af-b78c-45cb-9f4e-ef4b2a5eb0f9",
    "days_since_last_survey": 33,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-25"
      },
      {
        "type": "webinar",
        "date": "2025-01-25"
      },
      {
        "type": "detail",
        "date": "2025-01-30"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836365"
  },
  {
    "survey_id": "82838bfe-eb2f-4b3c-9f2c-672b665d09fa",
    "hcp_id": "HCP_000031",
    "survey_date": "2025-02-14",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": -1,
    "awareness_score": 3,
    "favorability_score": 6,
    "previous_survey_id": "c2284360-61f6-4689-a35f-cf0d55019436",
    "days_since_last_survey": 50,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-21"
      },
      {
        "type": "webinar",
        "date": "2025-01-31"
      },
      {
        "type": "sample",
        "date": "2025-01-30"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836398"
  },
  {
    "survey_id": "ae1b61d1-a80e-40a6-8142-e431c7d7e936",
    "hcp_id": "HCP_000031",
    "survey_date": "2025-03-19",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -2,
    "awareness_score": 6,
    "favorability_score": 5,
    "previous_survey_id": "82838bfe-eb2f-4b3c-9f2c-672b665d09fa",
    "days_since_last_survey": 89,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836421"
  },
  {
    "survey_id": "589df602-b9ac-413a-8f26-b9fab91818a0",
    "hcp_id": "HCP_000031",
    "survey_date": "2025-03-19",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 4,
    "awareness_score": 6,
    "favorability_score": 3,
    "previous_survey_id": "ae1b61d1-a80e-40a6-8142-e431c7d7e936",
    "days_since_last_survey": 60,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-03-16"
      },
      {
        "type": "email",
        "date": "2025-03-12"
      },
      {
        "type": "sample",
        "date": "2025-02-20"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836439"
  },
  {
    "survey_id": "01289255-7762-4d16-ae9d-140e1ef3153c",
    "hcp_id": "HCP_000031",
    "survey_date": "2025-03-19",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 5,
    "previous_survey_id": "589df602-b9ac-413a-8f26-b9fab91818a0",
    "days_since_last_survey": 44,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-03-18"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836488"
  },
  {
    "survey_id": "840f23b5-9f0d-4708-8803-bfa6c68f2e86",
    "hcp_id": "HCP_000031",
    "survey_date": "2025-04-23",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": -1,
    "awareness_score": 3,
    "favorability_score": 5,
    "previous_survey_id": "01289255-7762-4d16-ae9d-140e1ef3153c",
    "days_since_last_survey": 63,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836515"
  },
  {
    "survey_id": "76ef9f39-de63-42db-94a5-879a7f9f93e4",
    "hcp_id": "HCP_000031",
    "survey_date": "2025-04-23",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -3,
    "awareness_score": 6,
    "favorability_score": 2,
    "previous_survey_id": "840f23b5-9f0d-4708-8803-bfa6c68f2e86",
    "days_since_last_survey": 39,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-04-20"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836550"
  },
  {
    "survey_id": "b9c456a3-b414-44e7-a99e-365df8c14653",
    "hcp_id": "HCP_000031",
    "survey_date": "2025-04-23",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -1,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "76ef9f39-de63-42db-94a5-879a7f9f93e4",
    "days_since_last_survey": 66,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-04-16"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836566"
  },
  {
    "survey_id": "fb269a47-6f92-48c5-86ef-0c7623a8b1f0",
    "hcp_id": "HCP_000032",
    "survey_date": "2025-01-29",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 4,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-24"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836584"
  },
  {
    "survey_id": "0c9be748-8fb7-407c-a42d-863254efa822",
    "hcp_id": "HCP_000032",
    "survey_date": "2025-01-29",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 3,
    "awareness_score": 5,
    "favorability_score": 2,
    "previous_survey_id": "fb269a47-6f92-48c5-86ef-0c7623a8b1f0",
    "days_since_last_survey": 81,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-07"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836598"
  },
  {
    "survey_id": "84ab0e0b-374d-4fab-a99f-a8939e3f4827",
    "hcp_id": "HCP_000032",
    "survey_date": "2025-01-29",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -5,
    "awareness_score": 5,
    "favorability_score": 2,
    "previous_survey_id": "0c9be748-8fb7-407c-a42d-863254efa822",
    "days_since_last_survey": 72,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-22"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836613"
  },
  {
    "survey_id": "f193212e-32f5-4b29-a886-41db912976b3",
    "hcp_id": "HCP_000033",
    "survey_date": "2025-01-06",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 4,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2024-12-18"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836634"
  },
  {
    "survey_id": "8bf9f38b-1ad1-4b46-8136-9ec6c2399870",
    "hcp_id": "HCP_000033",
    "survey_date": "2025-01-06",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 6,
    "awareness_score": 5,
    "favorability_score": 3,
    "previous_survey_id": "f193212e-32f5-4b29-a886-41db912976b3",
    "days_since_last_survey": 45,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-02"
      },
      {
        "type": "sample",
        "date": "2024-12-07"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836653"
  },
  {
    "survey_id": "2e43fa13-7efc-4615-af7d-f9dd831b86ea",
    "hcp_id": "HCP_000033",
    "survey_date": "2025-01-06",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": -3,
    "awareness_score": 7,
    "favorability_score": 3,
    "previous_survey_id": "8bf9f38b-1ad1-4b46-8136-9ec6c2399870",
    "days_since_last_survey": 62,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2024-12-08"
      },
      {
        "type": "sample",
        "date": "2024-12-11"
      },
      {
        "type": "sample",
        "date": "2024-12-19"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836671"
  },
  {
    "survey_id": "fe2486c3-f644-4fce-817d-6f6b0cf1ccbd",
    "hcp_id": "HCP_000033",
    "survey_date": "2025-02-07",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 2,
    "awareness_score": 4,
    "favorability_score": 6,
    "previous_survey_id": "2e43fa13-7efc-4615-af7d-f9dd831b86ea",
    "days_since_last_survey": 70,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-20"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836706"
  },
  {
    "survey_id": "148cfc7c-4f76-4470-8dfa-54c28e05edc6",
    "hcp_id": "HCP_000033",
    "survey_date": "2025-02-07",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": -1,
    "awareness_score": 3,
    "favorability_score": 6,
    "previous_survey_id": "fe2486c3-f644-4fce-817d-6f6b0cf1ccbd",
    "days_since_last_survey": 39,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-14"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836720"
  },
  {
    "survey_id": "c3fa4309-aa36-4927-8184-5f26c3bb8674",
    "hcp_id": "HCP_000033",
    "survey_date": "2025-02-07",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -3,
    "awareness_score": 3,
    "favorability_score": 3,
    "previous_survey_id": "148cfc7c-4f76-4470-8dfa-54c28e05edc6",
    "days_since_last_survey": 74,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-20"
      },
      {
        "type": "email",
        "date": "2025-01-11"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836740"
  },
  {
    "survey_id": "5196a61e-5c6b-4664-934f-f4d46b101f0c",
    "hcp_id": "HCP_000034",
    "survey_date": "2025-01-25",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 6,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-17"
      },
      {
        "type": "sample",
        "date": "2025-01-16"
      },
      {
        "type": "detail",
        "date": "2024-12-28"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836770"
  },
  {
    "survey_id": "8d361300-7a87-463c-b1a0-06b6c57d3e70",
    "hcp_id": "HCP_000034",
    "survey_date": "2025-01-25",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 4,
    "awareness_score": 7,
    "favorability_score": 4,
    "previous_survey_id": "5196a61e-5c6b-4664-934f-f4d46b101f0c",
    "days_since_last_survey": 60,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-12"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836785"
  },
  {
    "survey_id": "bb5b3952-3fcd-4464-97d0-21e20908b254",
    "hcp_id": "HCP_000034",
    "survey_date": "2025-01-25",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -5,
    "awareness_score": 7,
    "favorability_score": 3,
    "previous_survey_id": "8d361300-7a87-463c-b1a0-06b6c57d3e70",
    "days_since_last_survey": 63,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836798"
  },
  {
    "survey_id": "92556f0f-8eda-4f10-87f1-049ed8e9d4a0",
    "hcp_id": "HCP_000034",
    "survey_date": "2025-03-01",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 4,
    "awareness_score": 6,
    "favorability_score": 4,
    "previous_survey_id": "bb5b3952-3fcd-4464-97d0-21e20908b254",
    "days_since_last_survey": 55,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836812"
  },
  {
    "survey_id": "fcc53095-8939-4793-bf5f-9277d4786289",
    "hcp_id": "HCP_000034",
    "survey_date": "2025-03-01",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -4,
    "awareness_score": 7,
    "favorability_score": 6,
    "previous_survey_id": "92556f0f-8eda-4f10-87f1-049ed8e9d4a0",
    "days_since_last_survey": 70,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836825"
  },
  {
    "survey_id": "33b2ae6c-cbb5-4e16-8a3d-0533dc9f1a64",
    "hcp_id": "HCP_000034",
    "survey_date": "2025-03-01",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -1,
    "awareness_score": 5,
    "favorability_score": 3,
    "previous_survey_id": "fcc53095-8939-4793-bf5f-9277d4786289",
    "days_since_last_survey": 42,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-11"
      },
      {
        "type": "webinar",
        "date": "2025-02-24"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836846"
  },
  {
    "survey_id": "bc955271-01cf-4895-aaaa-fb16817d21eb",
    "hcp_id": "HCP_000034",
    "survey_date": "2025-03-03",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": 0,
    "awareness_score": 5,
    "favorability_score": 5,
    "previous_survey_id": "33b2ae6c-cbb5-4e16-8a3d-0533dc9f1a64",
    "days_since_last_survey": 57,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-02-19"
      },
      {
        "type": "sample",
        "date": "2025-02-04"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836875"
  },
  {
    "survey_id": "f6ddcc05-a16d-4619-9c92-a677588664cb",
    "hcp_id": "HCP_000034",
    "survey_date": "2025-03-03",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 5,
    "awareness_score": 3,
    "favorability_score": 4,
    "previous_survey_id": "bc955271-01cf-4895-aaaa-fb16817d21eb",
    "days_since_last_survey": 36,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-02-05"
      },
      {
        "type": "webinar",
        "date": "2025-02-07"
      },
      {
        "type": "detail",
        "date": "2025-02-11"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836894"
  },
  {
    "survey_id": "f11d749a-177a-4497-8611-1a8853c56ebc",
    "hcp_id": "HCP_000034",
    "survey_date": "2025-03-03",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": -1,
    "awareness_score": 5,
    "favorability_score": 4,
    "previous_survey_id": "f6ddcc05-a16d-4619-9c92-a677588664cb",
    "days_since_last_survey": 57,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-24"
      },
      {
        "type": "sample",
        "date": "2025-02-06"
      },
      {
        "type": "sample",
        "date": "2025-02-13"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836916"
  },
  {
    "survey_id": "54d082e1-d46c-49c0-98f1-446c21bdc532",
    "hcp_id": "HCP_000034",
    "survey_date": "2025-04-28",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": -1,
    "awareness_score": 6,
    "favorability_score": 3,
    "previous_survey_id": "f11d749a-177a-4497-8611-1a8853c56ebc",
    "days_since_last_survey": 87,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836941"
  },
  {
    "survey_id": "779a7cbc-34fe-4df1-9ec8-b84cd51eb89e",
    "hcp_id": "HCP_000034",
    "survey_date": "2025-04-28",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -2,
    "awareness_score": 4,
    "favorability_score": 5,
    "previous_survey_id": "54d082e1-d46c-49c0-98f1-446c21bdc532",
    "days_since_last_survey": 56,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836958"
  },
  {
    "survey_id": "c55e9a1d-b686-4744-ae69-f4547ae2d544",
    "hcp_id": "HCP_000034",
    "survey_date": "2025-04-28",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": 0,
    "awareness_score": 5,
    "favorability_score": 7,
    "previous_survey_id": "779a7cbc-34fe-4df1-9ec8-b84cd51eb89e",
    "days_since_last_survey": 52,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836971"
  },
  {
    "survey_id": "ab876716-6bdf-41ec-96e7-d2247527877a",
    "hcp_id": "HCP_000035",
    "survey_date": "2025-01-27",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 5,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836986"
  },
  {
    "survey_id": "b25d182c-d0b0-4d7f-8383-d86e53c2874d",
    "hcp_id": "HCP_000035",
    "survey_date": "2025-01-27",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 0,
    "awareness_score": 5,
    "favorability_score": 4,
    "previous_survey_id": "ab876716-6bdf-41ec-96e7-d2247527877a",
    "days_since_last_survey": 41,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.836999"
  },
  {
    "survey_id": "d3773ca2-c743-4c49-adb1-65c34b128aff",
    "hcp_id": "HCP_000035",
    "survey_date": "2025-01-27",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -4,
    "awareness_score": 4,
    "favorability_score": 5,
    "previous_survey_id": "b25d182c-d0b0-4d7f-8383-d86e53c2874d",
    "days_since_last_survey": 46,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-25"
      },
      {
        "type": "email",
        "date": "2025-01-05"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837015"
  },
  {
    "survey_id": "d6e7e2cc-910f-4d75-8839-15fc1169a3cc",
    "hcp_id": "HCP_000036",
    "survey_date": "2025-01-14",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 7,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-06"
      },
      {
        "type": "email",
        "date": "2025-01-03"
      },
      {
        "type": "webinar",
        "date": "2025-01-03"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837044"
  },
  {
    "survey_id": "28d86827-3c9c-4c6f-96f8-60c98d6db27b",
    "hcp_id": "HCP_000036",
    "survey_date": "2025-01-14",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": -2,
    "awareness_score": 7,
    "favorability_score": 2,
    "previous_survey_id": "d6e7e2cc-910f-4d75-8839-15fc1169a3cc",
    "days_since_last_survey": 58,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2024-12-24"
      },
      {
        "type": "email",
        "date": "2024-12-25"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837061"
  },
  {
    "survey_id": "26a8cf10-2272-4d13-9ed9-4f08a0c19115",
    "hcp_id": "HCP_000036",
    "survey_date": "2025-01-14",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 2,
    "awareness_score": 4,
    "favorability_score": 4,
    "previous_survey_id": "28d86827-3c9c-4c6f-96f8-60c98d6db27b",
    "days_since_last_survey": 59,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-08"
      },
      {
        "type": "email",
        "date": "2025-01-07"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.837097"
  },
  {
    "survey_id": "74168031-dbff-4e20-8132-6b217a672367",
    "hcp_id": "HCP_000036",
    "survey_date": "2025-02-04",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 3,
    "favorability_score": 3,
    "previous_survey_id": "26a8cf10-2272-4d13-9ed9-4f08a0c19115",
    "days_since_last_survey": 41,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-21"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837136"
  },
  {
    "survey_id": "ed8559cc-3714-4eda-a6ba-5739486d0b0c",
    "hcp_id": "HCP_000036",
    "survey_date": "2025-02-04",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": -1,
    "awareness_score": 5,
    "favorability_score": 6,
    "previous_survey_id": "74168031-dbff-4e20-8132-6b217a672367",
    "days_since_last_survey": 69,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-25"
      },
      {
        "type": "email",
        "date": "2025-02-01"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837167"
  },
  {
    "survey_id": "88660798-2c85-4e90-bab3-26936d7272d0",
    "hcp_id": "HCP_000036",
    "survey_date": "2025-02-04",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 0,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "ed8559cc-3714-4eda-a6ba-5739486d0b0c",
    "days_since_last_survey": 87,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837179"
  },
  {
    "survey_id": "c1ec796b-342f-446a-81b8-6b02392da39b",
    "hcp_id": "HCP_000037",
    "survey_date": "2025-01-28",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 4,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-27"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837197"
  },
  {
    "survey_id": "e68fa206-7139-49f4-846e-430887c47747",
    "hcp_id": "HCP_000037",
    "survey_date": "2025-01-28",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 2,
    "awareness_score": 7,
    "favorability_score": 7,
    "previous_survey_id": "c1ec796b-342f-446a-81b8-6b02392da39b",
    "days_since_last_survey": 76,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-06"
      },
      {
        "type": "detail",
        "date": "2025-01-23"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837213"
  },
  {
    "survey_id": "935ddd14-bb06-4594-a7d6-7e32f7aa40fd",
    "hcp_id": "HCP_000037",
    "survey_date": "2025-01-28",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -1,
    "awareness_score": 7,
    "favorability_score": 6,
    "previous_survey_id": "e68fa206-7139-49f4-846e-430887c47747",
    "days_since_last_survey": 63,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-12"
      },
      {
        "type": "webinar",
        "date": "2025-01-19"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.837229"
  },
  {
    "survey_id": "846650cf-1cc7-4854-8d66-2aeafc8953c4",
    "hcp_id": "HCP_000037",
    "survey_date": "2025-02-06",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -1,
    "awareness_score": 4,
    "favorability_score": 3,
    "previous_survey_id": "935ddd14-bb06-4594-a7d6-7e32f7aa40fd",
    "days_since_last_survey": 90,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-27"
      },
      {
        "type": "sample",
        "date": "2025-01-20"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837248"
  },
  {
    "survey_id": "aacc9475-59e5-4daa-b133-0647e6957dc7",
    "hcp_id": "HCP_000037",
    "survey_date": "2025-02-06",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 4,
    "awareness_score": 4,
    "favorability_score": 4,
    "previous_survey_id": "846650cf-1cc7-4854-8d66-2aeafc8953c4",
    "days_since_last_survey": 46,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-14"
      },
      {
        "type": "detail",
        "date": "2025-01-07"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837290"
  },
  {
    "survey_id": "5d368890-b25e-4e33-9ccd-65f8ad077d9f",
    "hcp_id": "HCP_000037",
    "survey_date": "2025-02-06",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -2,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "aacc9475-59e5-4daa-b133-0647e6957dc7",
    "days_since_last_survey": 80,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-15"
      },
      {
        "type": "sample",
        "date": "2025-01-16"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837315"
  },
  {
    "survey_id": "3f833fa4-523b-4e01-b78a-25af070826d0",
    "hcp_id": "HCP_000037",
    "survey_date": "2025-03-31",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 2,
    "awareness_score": 6,
    "favorability_score": 4,
    "previous_survey_id": "5d368890-b25e-4e33-9ccd-65f8ad077d9f",
    "days_since_last_survey": 30,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-03-10"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837346"
  },
  {
    "survey_id": "6a7f8b94-5f27-41da-b1bd-530e6e5ae2fc",
    "hcp_id": "HCP_000037",
    "survey_date": "2025-03-31",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 1,
    "awareness_score": 7,
    "favorability_score": 7,
    "previous_survey_id": "3f833fa4-523b-4e01-b78a-25af070826d0",
    "days_since_last_survey": 32,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-03-16"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.837366"
  },
  {
    "survey_id": "07610d8c-4261-4c6b-9905-32a326841369",
    "hcp_id": "HCP_000037",
    "survey_date": "2025-03-31",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": -1,
    "awareness_score": 5,
    "favorability_score": 2,
    "previous_survey_id": "6a7f8b94-5f27-41da-b1bd-530e6e5ae2fc",
    "days_since_last_survey": 30,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-03-05"
      },
      {
        "type": "sample",
        "date": "2025-03-30"
      },
      {
        "type": "email",
        "date": "2025-03-19"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837398"
  },
  {
    "survey_id": "59847c7a-5acc-4224-9dc8-d464efe34c92",
    "hcp_id": "HCP_000038",
    "survey_date": "2025-01-31",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 7,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837422"
  },
  {
    "survey_id": "cc26a7fd-6ed0-43e2-bc21-8865987c5bbb",
    "hcp_id": "HCP_000038",
    "survey_date": "2025-01-31",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -2,
    "awareness_score": 6,
    "favorability_score": 2,
    "previous_survey_id": "59847c7a-5acc-4224-9dc8-d464efe34c92",
    "days_since_last_survey": 38,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-19"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837440"
  },
  {
    "survey_id": "39294026-556f-4cdd-a035-9583e299806a",
    "hcp_id": "HCP_000038",
    "survey_date": "2025-01-31",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 3,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "cc26a7fd-6ed0-43e2-bc21-8865987c5bbb",
    "days_since_last_survey": 61,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-14"
      },
      {
        "type": "detail",
        "date": "2025-01-28"
      },
      {
        "type": "detail",
        "date": "2025-01-19"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837461"
  },
  {
    "survey_id": "dc442a91-511a-4dae-837f-7896446392be",
    "hcp_id": "HCP_000038",
    "survey_date": "2025-02-24",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -3,
    "awareness_score": 6,
    "favorability_score": 7,
    "previous_survey_id": "39294026-556f-4cdd-a035-9583e299806a",
    "days_since_last_survey": 46,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-31"
      },
      {
        "type": "email",
        "date": "2025-02-02"
      },
      {
        "type": "detail",
        "date": "2025-02-18"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837491"
  },
  {
    "survey_id": "3950930f-76e9-47db-a42b-b85cd51ddac4",
    "hcp_id": "HCP_000038",
    "survey_date": "2025-02-24",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 4,
    "awareness_score": 6,
    "favorability_score": 6,
    "previous_survey_id": "dc442a91-511a-4dae-837f-7896446392be",
    "days_since_last_survey": 71,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-02-23"
      },
      {
        "type": "detail",
        "date": "2025-01-26"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837510"
  },
  {
    "survey_id": "a5d89657-3257-41d0-907e-f45219d74f65",
    "hcp_id": "HCP_000038",
    "survey_date": "2025-02-24",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -4,
    "awareness_score": 4,
    "favorability_score": 2,
    "previous_survey_id": "3950930f-76e9-47db-a42b-b85cd51ddac4",
    "days_since_last_survey": 51,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-01"
      },
      {
        "type": "sample",
        "date": "2025-02-08"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837527"
  },
  {
    "survey_id": "428d7226-e608-450d-b403-b5e2544acb28",
    "hcp_id": "HCP_000039",
    "survey_date": "2025-01-30",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 0,
    "awareness_score": 3,
    "favorability_score": 7,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-22"
      },
      {
        "type": "webinar",
        "date": "2025-01-01"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837555"
  },
  {
    "survey_id": "3c968e16-5fb7-4102-a410-73a60099106d",
    "hcp_id": "HCP_000039",
    "survey_date": "2025-01-30",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": -1,
    "awareness_score": 7,
    "favorability_score": 4,
    "previous_survey_id": "428d7226-e608-450d-b403-b5e2544acb28",
    "days_since_last_survey": 90,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-26"
      },
      {
        "type": "sample",
        "date": "2025-01-26"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837578"
  },
  {
    "survey_id": "8d2e4e0d-ffe8-485f-8016-3622e6b08ee3",
    "hcp_id": "HCP_000039",
    "survey_date": "2025-01-30",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -4,
    "awareness_score": 7,
    "favorability_score": 7,
    "previous_survey_id": "3c968e16-5fb7-4102-a410-73a60099106d",
    "days_since_last_survey": 34,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837605"
  },
  {
    "survey_id": "76d74c8c-5131-4b02-9ebd-a4fbaf9d340e",
    "hcp_id": "HCP_000039",
    "survey_date": "2025-02-04",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 5,
    "awareness_score": 4,
    "favorability_score": 2,
    "previous_survey_id": "8d2e4e0d-ffe8-485f-8016-3622e6b08ee3",
    "days_since_last_survey": 49,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-05"
      },
      {
        "type": "sample",
        "date": "2025-01-13"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837637"
  },
  {
    "survey_id": "d235ca6a-ccc9-4626-b150-3c7d47a8c2a7",
    "hcp_id": "HCP_000039",
    "survey_date": "2025-02-04",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -3,
    "awareness_score": 6,
    "favorability_score": 7,
    "previous_survey_id": "76d74c8c-5131-4b02-9ebd-a4fbaf9d340e",
    "days_since_last_survey": 31,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-02-02"
      },
      {
        "type": "sample",
        "date": "2025-01-06"
      },
      {
        "type": "detail",
        "date": "2025-02-03"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837656"
  },
  {
    "survey_id": "25a9c637-e9a1-4171-998c-56f1d9e950d4",
    "hcp_id": "HCP_000039",
    "survey_date": "2025-02-04",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 3,
    "awareness_score": 3,
    "favorability_score": 4,
    "previous_survey_id": "d235ca6a-ccc9-4626-b150-3c7d47a8c2a7",
    "days_since_last_survey": 51,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837677"
  },
  {
    "survey_id": "803e9f3d-f379-4d84-a7e6-38a2028a9884",
    "hcp_id": "HCP_000039",
    "survey_date": "2025-03-18",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 0,
    "awareness_score": 3,
    "favorability_score": 3,
    "previous_survey_id": "25a9c637-e9a1-4171-998c-56f1d9e950d4",
    "days_since_last_survey": 36,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837694"
  },
  {
    "survey_id": "f4bb15a2-0122-44ce-b60d-0d1cb55382ee",
    "hcp_id": "HCP_000039",
    "survey_date": "2025-03-18",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": -2,
    "awareness_score": 3,
    "favorability_score": 4,
    "previous_survey_id": "803e9f3d-f379-4d84-a7e6-38a2028a9884",
    "days_since_last_survey": 86,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-02-20"
      },
      {
        "type": "webinar",
        "date": "2025-02-22"
      },
      {
        "type": "email",
        "date": "2025-03-14"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837713"
  },
  {
    "survey_id": "51e26e58-c51a-4b44-87d2-f9912a5b6d64",
    "hcp_id": "HCP_000039",
    "survey_date": "2025-03-18",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 1,
    "awareness_score": 5,
    "favorability_score": 2,
    "previous_survey_id": "f4bb15a2-0122-44ce-b60d-0d1cb55382ee",
    "days_since_last_survey": 70,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-03-06"
      },
      {
        "type": "email",
        "date": "2025-03-13"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837738"
  },
  {
    "survey_id": "21da5140-15ce-4532-aa00-fa9df14457a4",
    "hcp_id": "HCP_000040",
    "survey_date": "2025-01-16",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 2,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837761"
  },
  {
    "survey_id": "3592120f-7d43-42b6-9469-c76e8ed81df7",
    "hcp_id": "HCP_000040",
    "survey_date": "2025-01-16",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 3,
    "awareness_score": 4,
    "favorability_score": 3,
    "previous_survey_id": "21da5140-15ce-4532-aa00-fa9df14457a4",
    "days_since_last_survey": 45,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837774"
  },
  {
    "survey_id": "6d241e57-60d0-484f-8136-ddc3fedd7ad5",
    "hcp_id": "HCP_000040",
    "survey_date": "2025-01-16",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -6,
    "awareness_score": 7,
    "favorability_score": 5,
    "previous_survey_id": "3592120f-7d43-42b6-9469-c76e8ed81df7",
    "days_since_last_survey": 30,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-07"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837790"
  },
  {
    "survey_id": "de9f061e-d1a3-45b8-86fe-8558ac740969",
    "hcp_id": "HCP_000040",
    "survey_date": "2025-02-26",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 6,
    "awareness_score": 7,
    "favorability_score": 6,
    "previous_survey_id": "6d241e57-60d0-484f-8136-ddc3fedd7ad5",
    "days_since_last_survey": 72,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-09"
      },
      {
        "type": "webinar",
        "date": "2025-02-14"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837824"
  },
  {
    "survey_id": "5d179249-8584-4705-bacf-2e36e38a3c30",
    "hcp_id": "HCP_000040",
    "survey_date": "2025-02-26",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": -3,
    "awareness_score": 3,
    "favorability_score": 6,
    "previous_survey_id": "de9f061e-d1a3-45b8-86fe-8558ac740969",
    "days_since_last_survey": 57,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.837857"
  },
  {
    "survey_id": "777a51d7-0742-41f9-851b-e25a630e7d2e",
    "hcp_id": "HCP_000040",
    "survey_date": "2025-02-26",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 5,
    "previous_survey_id": "5d179249-8584-4705-bacf-2e36e38a3c30",
    "days_since_last_survey": 90,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-04"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837872"
  },
  {
    "survey_id": "a72bc560-002f-41de-9cdf-a87d4dc47b66",
    "hcp_id": "HCP_000040",
    "survey_date": "2025-03-14",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 1,
    "awareness_score": 6,
    "favorability_score": 6,
    "previous_survey_id": "777a51d7-0742-41f9-851b-e25a630e7d2e",
    "days_since_last_survey": 53,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-15"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837889"
  },
  {
    "survey_id": "8a8e3c31-476b-41d4-94e6-99a948f04c58",
    "hcp_id": "HCP_000040",
    "survey_date": "2025-03-14",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": -1,
    "awareness_score": 6,
    "favorability_score": 7,
    "previous_survey_id": "a72bc560-002f-41de-9cdf-a87d4dc47b66",
    "days_since_last_survey": 65,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837901"
  },
  {
    "survey_id": "be882f2f-b5a7-4a18-92a2-64198ea6f72e",
    "hcp_id": "HCP_000040",
    "survey_date": "2025-03-14",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 1,
    "awareness_score": 7,
    "favorability_score": 4,
    "previous_survey_id": "8a8e3c31-476b-41d4-94e6-99a948f04c58",
    "days_since_last_survey": 90,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837914"
  },
  {
    "survey_id": "18f69eda-fc1d-4370-963f-a7bcdaf5dac8",
    "hcp_id": "HCP_000041",
    "survey_date": "2025-01-31",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 0,
    "awareness_score": 5,
    "favorability_score": 3,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837933"
  },
  {
    "survey_id": "4f879866-435b-4a97-aeb4-e1da47cf493d",
    "hcp_id": "HCP_000041",
    "survey_date": "2025-01-31",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -1,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "18f69eda-fc1d-4370-963f-a7bcdaf5dac8",
    "days_since_last_survey": 34,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-25"
      },
      {
        "type": "webinar",
        "date": "2025-01-12"
      },
      {
        "type": "sample",
        "date": "2025-01-17"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837951"
  },
  {
    "survey_id": "19929fee-ab51-458e-843e-556e7e28d5d5",
    "hcp_id": "HCP_000041",
    "survey_date": "2025-01-31",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 1,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "4f879866-435b-4a97-aeb4-e1da47cf493d",
    "days_since_last_survey": 68,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-19"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837969"
  },
  {
    "survey_id": "904be998-f9d7-45b4-94e2-5a16b040645c",
    "hcp_id": "HCP_000041",
    "survey_date": "2025-02-07",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -2,
    "awareness_score": 4,
    "favorability_score": 5,
    "previous_survey_id": "19929fee-ab51-458e-843e-556e7e28d5d5",
    "days_since_last_survey": 70,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-28"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.837997"
  },
  {
    "survey_id": "eda910c5-ac2b-496d-9a9d-88041cf8842c",
    "hcp_id": "HCP_000041",
    "survey_date": "2025-02-07",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 2,
    "awareness_score": 3,
    "favorability_score": 5,
    "previous_survey_id": "904be998-f9d7-45b4-94e2-5a16b040645c",
    "days_since_last_survey": 35,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-02-01"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838013"
  },
  {
    "survey_id": "3be36d87-f6ee-4be2-a74e-1f3fbb5f04da",
    "hcp_id": "HCP_000041",
    "survey_date": "2025-02-07",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 0,
    "awareness_score": 3,
    "favorability_score": 5,
    "previous_survey_id": "eda910c5-ac2b-496d-9a9d-88041cf8842c",
    "days_since_last_survey": 90,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-04"
      },
      {
        "type": "sample",
        "date": "2025-01-26"
      },
      {
        "type": "email",
        "date": "2025-02-02"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838036"
  },
  {
    "survey_id": "8f7cf0f3-7a74-4239-a6eb-ec9c909e1587",
    "hcp_id": "HCP_000042",
    "survey_date": "2025-01-26",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 5,
    "favorability_score": 4,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838059"
  },
  {
    "survey_id": "34558ec7-4c6f-4b1b-96fc-6c2cad3946e7",
    "hcp_id": "HCP_000042",
    "survey_date": "2025-01-26",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -6,
    "awareness_score": 3,
    "favorability_score": 6,
    "previous_survey_id": "8f7cf0f3-7a74-4239-a6eb-ec9c909e1587",
    "days_since_last_survey": 32,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-21"
      },
      {
        "type": "sample",
        "date": "2024-12-28"
      },
      {
        "type": "email",
        "date": "2025-01-08"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838080"
  },
  {
    "survey_id": "12276e39-1b0a-43b1-9405-9cf44d89a763",
    "hcp_id": "HCP_000042",
    "survey_date": "2025-01-26",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 4,
    "awareness_score": 5,
    "favorability_score": 4,
    "previous_survey_id": "34558ec7-4c6f-4b1b-96fc-6c2cad3946e7",
    "days_since_last_survey": 79,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2024-12-27"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838105"
  },
  {
    "survey_id": "92c382fb-7777-4f83-a1c9-68ab14b22a52",
    "hcp_id": "HCP_000042",
    "survey_date": "2025-01-31",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 2,
    "awareness_score": 6,
    "favorability_score": 2,
    "previous_survey_id": "12276e39-1b0a-43b1-9405-9cf44d89a763",
    "days_since_last_survey": 63,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-23"
      },
      {
        "type": "email",
        "date": "2025-01-19"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838123"
  },
  {
    "survey_id": "2be07558-db42-4d54-bbc1-1a40e9473f5c",
    "hcp_id": "HCP_000042",
    "survey_date": "2025-01-31",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": -3,
    "awareness_score": 7,
    "favorability_score": 3,
    "previous_survey_id": "92c382fb-7777-4f83-a1c9-68ab14b22a52",
    "days_since_last_survey": 60,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-11"
      },
      {
        "type": "webinar",
        "date": "2025-01-13"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838139"
  },
  {
    "survey_id": "b7c951ae-9eba-4d19-a925-0e2ce702b88c",
    "hcp_id": "HCP_000042",
    "survey_date": "2025-01-31",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 2,
    "awareness_score": 3,
    "favorability_score": 3,
    "previous_survey_id": "2be07558-db42-4d54-bbc1-1a40e9473f5c",
    "days_since_last_survey": 43,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.838152"
  },
  {
    "survey_id": "dc0eeb06-6c64-4367-ba95-6b99aea5bf75",
    "hcp_id": "HCP_000042",
    "survey_date": "2025-03-30",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -5,
    "awareness_score": 5,
    "favorability_score": 4,
    "previous_survey_id": "b7c951ae-9eba-4d19-a925-0e2ce702b88c",
    "days_since_last_survey": 63,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-03-18"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838176"
  },
  {
    "survey_id": "5bef5e74-c90c-4bb7-8a45-53bd3417f666",
    "hcp_id": "HCP_000042",
    "survey_date": "2025-03-30",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 6,
    "awareness_score": 3,
    "favorability_score": 3,
    "previous_survey_id": "dc0eeb06-6c64-4367-ba95-6b99aea5bf75",
    "days_since_last_survey": 59,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-03-24"
      },
      {
        "type": "sample",
        "date": "2025-03-14"
      },
      {
        "type": "webinar",
        "date": "2025-03-06"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838207"
  },
  {
    "survey_id": "3816b84c-b498-4b22-89b6-9bae6f93608b",
    "hcp_id": "HCP_000042",
    "survey_date": "2025-03-30",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -4,
    "awareness_score": 5,
    "favorability_score": 3,
    "previous_survey_id": "5bef5e74-c90c-4bb7-8a45-53bd3417f666",
    "days_since_last_survey": 86,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838228"
  },
  {
    "survey_id": "1efc8aa2-1f76-46ae-9bf8-d61e54da6640",
    "hcp_id": "HCP_000043",
    "survey_date": "2025-01-27",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 4,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": false,
    "created_at": "2025-11-28T15:39:47.838269"
  },
  {
    "survey_id": "bfd563cf-5f6c-47aa-919a-17b036320e62",
    "hcp_id": "HCP_000043",
    "survey_date": "2025-01-27",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -1,
    "awareness_score": 6,
    "favorability_score": 5,
    "previous_survey_id": "1efc8aa2-1f76-46ae-9bf8-d61e54da6640",
    "days_since_last_survey": 49,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-19"
      },
      {
        "type": "detail",
        "date": "2025-01-16"
      },
      {
        "type": "webinar",
        "date": "2025-01-06"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838293"
  },
  {
    "survey_id": "d899164f-7c11-45c4-ac0f-eec452c1226f",
    "hcp_id": "HCP_000043",
    "survey_date": "2025-01-27",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 4,
    "awareness_score": 3,
    "favorability_score": 7,
    "previous_survey_id": "bfd563cf-5f6c-47aa-919a-17b036320e62",
    "days_since_last_survey": 72,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-23"
      },
      {
        "type": "email",
        "date": "2025-01-11"
      },
      {
        "type": "detail",
        "date": "2025-01-24"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838322"
  },
  {
    "survey_id": "1507e991-730d-4ebb-b4e7-dd8f2bccaaee",
    "hcp_id": "HCP_000043",
    "survey_date": "2025-03-01",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 5,
    "previous_survey_id": "d899164f-7c11-45c4-ac0f-eec452c1226f",
    "days_since_last_survey": 72,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-03"
      },
      {
        "type": "detail",
        "date": "2025-02-03"
      },
      {
        "type": "email",
        "date": "2025-02-05"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838351"
  },
  {
    "survey_id": "6e4b13d2-3a86-4a61-853a-e4fe263f50e2",
    "hcp_id": "HCP_000043",
    "survey_date": "2025-03-01",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": -3,
    "awareness_score": 7,
    "favorability_score": 7,
    "previous_survey_id": "1507e991-730d-4ebb-b4e7-dd8f2bccaaee",
    "days_since_last_survey": 30,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-02-19"
      },
      {
        "type": "detail",
        "date": "2025-02-26"
      },
      {
        "type": "detail",
        "date": "2025-02-18"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838368"
  },
  {
    "survey_id": "524e91c2-27f0-4a04-aac7-25cfe0ec4538",
    "hcp_id": "HCP_000043",
    "survey_date": "2025-03-01",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 3,
    "previous_survey_id": "6e4b13d2-3a86-4a61-853a-e4fe263f50e2",
    "days_since_last_survey": 73,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-10"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838382"
  },
  {
    "survey_id": "f70625e7-02b6-4dab-8cf7-8956a10cfbd8",
    "hcp_id": "HCP_000043",
    "survey_date": "2025-03-19",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 1,
    "awareness_score": 7,
    "favorability_score": 4,
    "previous_survey_id": "524e91c2-27f0-4a04-aac7-25cfe0ec4538",
    "days_since_last_survey": 67,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-20"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838398"
  },
  {
    "survey_id": "fe4303c6-0d2f-42b4-9aae-793e9880d3ff",
    "hcp_id": "HCP_000043",
    "survey_date": "2025-03-19",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 4,
    "awareness_score": 5,
    "favorability_score": 5,
    "previous_survey_id": "f70625e7-02b6-4dab-8cf7-8956a10cfbd8",
    "days_since_last_survey": 47,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838412"
  },
  {
    "survey_id": "f910dc3a-ac2c-4ad8-ab03-7ea925283e85",
    "hcp_id": "HCP_000043",
    "survey_date": "2025-03-19",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 6,
    "previous_survey_id": "fe4303c6-0d2f-42b4-9aae-793e9880d3ff",
    "days_since_last_survey": 75,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-03-04"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838425"
  },
  {
    "survey_id": "5ad81e9f-2d8e-4494-960c-2d1b77312fd2",
    "hcp_id": "HCP_000044",
    "survey_date": "2025-01-29",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 5,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-18"
      },
      {
        "type": "sample",
        "date": "2025-01-07"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838443"
  },
  {
    "survey_id": "b452bd1a-6c38-46c1-aca7-ea1d6d1427f8",
    "hcp_id": "HCP_000044",
    "survey_date": "2025-01-29",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": 1,
    "awareness_score": 7,
    "favorability_score": 3,
    "previous_survey_id": "5ad81e9f-2d8e-4494-960c-2d1b77312fd2",
    "days_since_last_survey": 82,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-20"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838463"
  },
  {
    "survey_id": "577d5754-a6ef-4217-8b65-09b45c07e7ee",
    "hcp_id": "HCP_000044",
    "survey_date": "2025-01-29",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -1,
    "awareness_score": 7,
    "favorability_score": 5,
    "previous_survey_id": "b452bd1a-6c38-46c1-aca7-ea1d6d1427f8",
    "days_since_last_survey": 40,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-01"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838476"
  },
  {
    "survey_id": "578ccf1e-5e38-4b45-8d65-0b4950987979",
    "hcp_id": "HCP_000044",
    "survey_date": "2025-02-07",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 3,
    "awareness_score": 6,
    "favorability_score": 2,
    "previous_survey_id": "577d5754-a6ef-4217-8b65-09b45c07e7ee",
    "days_since_last_survey": 42,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838490"
  },
  {
    "survey_id": "9e0be7f1-fa6b-46de-80d6-3856013cbd9a",
    "hcp_id": "HCP_000044",
    "survey_date": "2025-02-07",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 1,
    "awareness_score": 3,
    "favorability_score": 3,
    "previous_survey_id": "578ccf1e-5e38-4b45-8d65-0b4950987979",
    "days_since_last_survey": 32,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838504"
  },
  {
    "survey_id": "51812e69-95aa-43ff-addd-86ef5541a247",
    "hcp_id": "HCP_000044",
    "survey_date": "2025-02-07",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 1,
    "awareness_score": 5,
    "favorability_score": 7,
    "previous_survey_id": "9e0be7f1-fa6b-46de-80d6-3856013cbd9a",
    "days_since_last_survey": 67,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-11"
      },
      {
        "type": "email",
        "date": "2025-02-03"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838521"
  },
  {
    "survey_id": "93700a58-cd24-4700-96ec-2f722a2bf922",
    "hcp_id": "HCP_000045",
    "survey_date": "2025-01-08",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 6,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838543"
  },
  {
    "survey_id": "21d079f7-a024-4609-a6dc-15de760de4c8",
    "hcp_id": "HCP_000045",
    "survey_date": "2025-01-08",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 1,
    "awareness_score": 7,
    "favorability_score": 2,
    "previous_survey_id": "93700a58-cd24-4700-96ec-2f722a2bf922",
    "days_since_last_survey": 41,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2024-12-27"
      },
      {
        "type": "email",
        "date": "2025-01-04"
      },
      {
        "type": "sample",
        "date": "2025-01-02"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838560"
  },
  {
    "survey_id": "40ff3f00-1197-4559-8661-62baddca3748",
    "hcp_id": "HCP_000045",
    "survey_date": "2025-01-08",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -6,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "21d079f7-a024-4609-a6dc-15de760de4c8",
    "days_since_last_survey": 47,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2024-12-19"
      },
      {
        "type": "webinar",
        "date": "2024-12-19"
      },
      {
        "type": "detail",
        "date": "2024-12-10"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838577"
  },
  {
    "survey_id": "231001c4-6218-4bf9-9606-1cc5014131ae",
    "hcp_id": "HCP_000045",
    "survey_date": "2025-02-18",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 5,
    "awareness_score": 3,
    "favorability_score": 5,
    "previous_survey_id": "40ff3f00-1197-4559-8661-62baddca3748",
    "days_since_last_survey": 83,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-20"
      },
      {
        "type": "webinar",
        "date": "2025-02-14"
      },
      {
        "type": "sample",
        "date": "2025-02-03"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838603"
  },
  {
    "survey_id": "65abbb66-1bb9-4221-9aad-6c86a4b2aa8e",
    "hcp_id": "HCP_000045",
    "survey_date": "2025-02-18",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -5,
    "awareness_score": 6,
    "favorability_score": 3,
    "previous_survey_id": "231001c4-6218-4bf9-9606-1cc5014131ae",
    "days_since_last_survey": 68,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-01-31"
      },
      {
        "type": "webinar",
        "date": "2025-01-27"
      },
      {
        "type": "sample",
        "date": "2025-01-21"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838620"
  },
  {
    "survey_id": "23592697-0aa4-46b8-837d-652b4c2918c3",
    "hcp_id": "HCP_000045",
    "survey_date": "2025-02-18",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 4,
    "previous_survey_id": "65abbb66-1bb9-4221-9aad-6c86a4b2aa8e",
    "days_since_last_survey": 33,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-01-24"
      },
      {
        "type": "detail",
        "date": "2025-02-05"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838650"
  },
  {
    "survey_id": "7de4f9fb-88ae-49d4-8dfb-b6ef52b8267a",
    "hcp_id": "HCP_000045",
    "survey_date": "2025-03-15",
    "survey_type": "detail_followup",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 2,
    "intent_to_prescribe_change": 1,
    "awareness_score": 3,
    "favorability_score": 7,
    "previous_survey_id": "23592697-0aa4-46b8-837d-652b4c2918c3",
    "days_since_last_survey": 85,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-02-24"
      },
      {
        "type": "webinar",
        "date": "2025-02-19"
      },
      {
        "type": "email",
        "date": "2025-02-13"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838684"
  },
  {
    "survey_id": "0e0793a0-c6e6-4bd6-912e-374f00722572",
    "hcp_id": "HCP_000045",
    "survey_date": "2025-03-15",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -1,
    "awareness_score": 7,
    "favorability_score": 4,
    "previous_survey_id": "7de4f9fb-88ae-49d4-8dfb-b6ef52b8267a",
    "days_since_last_survey": 58,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-02-19"
      },
      {
        "type": "webinar",
        "date": "2025-03-10"
      },
      {
        "type": "detail",
        "date": "2025-02-23"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838715"
  },
  {
    "survey_id": "3c77ff7f-2499-4418-b54d-0400f6c8547c",
    "hcp_id": "HCP_000045",
    "survey_date": "2025-03-15",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 5,
    "awareness_score": 4,
    "favorability_score": 7,
    "previous_survey_id": "0e0793a0-c6e6-4bd6-912e-374f00722572",
    "days_since_last_survey": 81,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-03-01"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838750"
  },
  {
    "survey_id": "71afd726-6fbf-42a8-a1a6-0de12abd69af",
    "hcp_id": "HCP_000046",
    "survey_date": "2025-01-05",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 0,
    "awareness_score": 7,
    "favorability_score": 2,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838767"
  },
  {
    "survey_id": "53730c7c-209f-40bc-86b3-0646a1bfe158",
    "hcp_id": "HCP_000046",
    "survey_date": "2025-01-05",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": -2,
    "awareness_score": 6,
    "favorability_score": 6,
    "previous_survey_id": "71afd726-6fbf-42a8-a1a6-0de12abd69af",
    "days_since_last_survey": 65,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838779"
  },
  {
    "survey_id": "3afc2066-e9b3-4a57-bbae-c6935af67a83",
    "hcp_id": "HCP_000046",
    "survey_date": "2025-01-05",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 3,
    "awareness_score": 7,
    "favorability_score": 7,
    "previous_survey_id": "53730c7c-209f-40bc-86b3-0646a1bfe158",
    "days_since_last_survey": 56,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2024-12-14"
      },
      {
        "type": "webinar",
        "date": "2024-12-08"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838795"
  },
  {
    "survey_id": "1ce78c07-a732-4abe-a95d-c67e5350e485",
    "hcp_id": "HCP_000046",
    "survey_date": "2025-02-28",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 5,
    "favorability_score": 7,
    "previous_survey_id": "3afc2066-e9b3-4a57-bbae-c6935af67a83",
    "days_since_last_survey": 81,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-02-25"
      },
      {
        "type": "email",
        "date": "2025-02-12"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838822"
  },
  {
    "survey_id": "0580829d-9518-4470-b8df-bfe4240f2883",
    "hcp_id": "HCP_000046",
    "survey_date": "2025-02-28",
    "survey_type": "market_research",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -4,
    "awareness_score": 7,
    "favorability_score": 3,
    "previous_survey_id": "1ce78c07-a732-4abe-a95d-c67e5350e485",
    "days_since_last_survey": 83,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838840"
  },
  {
    "survey_id": "6f6077fc-dae2-4151-bd94-e6ff14e3f605",
    "hcp_id": "HCP_000046",
    "survey_date": "2025-02-28",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 0,
    "awareness_score": 5,
    "favorability_score": 5,
    "previous_survey_id": "0580829d-9518-4470-b8df-bfe4240f2883",
    "days_since_last_survey": 59,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-31"
      },
      {
        "type": "webinar",
        "date": "2025-02-24"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838858"
  },
  {
    "survey_id": "4ee6a29a-a1b9-4dbe-b48f-6f9a0066fb52",
    "hcp_id": "HCP_000046",
    "survey_date": "2025-03-13",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 2,
    "awareness_score": 7,
    "favorability_score": 3,
    "previous_survey_id": "6f6077fc-dae2-4151-bd94-e6ff14e3f605",
    "days_since_last_survey": 46,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838888"
  },
  {
    "survey_id": "8e658fa8-ab6b-4dc2-ab40-b6a9d74e823c",
    "hcp_id": "HCP_000046",
    "survey_date": "2025-03-13",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -2,
    "awareness_score": 4,
    "favorability_score": 4,
    "previous_survey_id": "4ee6a29a-a1b9-4dbe-b48f-6f9a0066fb52",
    "days_since_last_survey": 67,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838901"
  },
  {
    "survey_id": "98cb01d3-3a2f-4948-9139-91f21103d713",
    "hcp_id": "HCP_000046",
    "survey_date": "2025-03-13",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 6,
    "previous_survey_id": "8e658fa8-ab6b-4dc2-ab40-b6a9d74e823c",
    "days_since_last_survey": 87,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-24"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838916"
  },
  {
    "survey_id": "5a48ac77-d1dc-4e92-ae4e-785028aa248a",
    "hcp_id": "HCP_000047",
    "survey_date": "2025-01-14",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 4,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838944"
  },
  {
    "survey_id": "669c3741-2453-40cf-9139-7b179a80ee7c",
    "hcp_id": "HCP_000047",
    "survey_date": "2025-01-14",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 0,
    "awareness_score": 3,
    "favorability_score": 7,
    "previous_survey_id": "5a48ac77-d1dc-4e92-ae4e-785028aa248a",
    "days_since_last_survey": 60,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-05"
      },
      {
        "type": "webinar",
        "date": "2024-12-29"
      },
      {
        "type": "sample",
        "date": "2025-01-11"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838962"
  },
  {
    "survey_id": "1f21fafe-c621-444d-994c-3b3c4b906ee5",
    "hcp_id": "HCP_000047",
    "survey_date": "2025-01-14",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 2,
    "previous_survey_id": "669c3741-2453-40cf-9139-7b179a80ee7c",
    "days_since_last_survey": 75,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2024-12-28"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.838991"
  },
  {
    "survey_id": "2d8e5197-aa3e-457d-ba91-469dfdd947ed",
    "hcp_id": "HCP_000047",
    "survey_date": "2025-02-04",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 2,
    "awareness_score": 4,
    "favorability_score": 4,
    "previous_survey_id": "1f21fafe-c621-444d-994c-3b3c4b906ee5",
    "days_since_last_survey": 66,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839006"
  },
  {
    "survey_id": "1ce890e4-548a-4526-a065-8acae4c13196",
    "hcp_id": "HCP_000047",
    "survey_date": "2025-02-04",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 0,
    "awareness_score": 5,
    "favorability_score": 7,
    "previous_survey_id": "2d8e5197-aa3e-457d-ba91-469dfdd947ed",
    "days_since_last_survey": 82,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-05"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839020"
  },
  {
    "survey_id": "012abdca-2755-41a4-9ede-ef60bd01ea2c",
    "hcp_id": "HCP_000047",
    "survey_date": "2025-02-04",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -4,
    "awareness_score": 3,
    "favorability_score": 2,
    "previous_survey_id": "1ce890e4-548a-4526-a065-8acae4c13196",
    "days_since_last_survey": 79,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839036"
  },
  {
    "survey_id": "7cd655f1-f040-4505-ac4b-cf1a1835e927",
    "hcp_id": "HCP_000048",
    "survey_date": "2025-01-25",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 0,
    "awareness_score": 6,
    "favorability_score": 4,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-13"
      },
      {
        "type": "sample",
        "date": "2025-01-23"
      },
      {
        "type": "sample",
        "date": "2025-01-01"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839065"
  },
  {
    "survey_id": "bc2d1659-e303-42dd-adb0-a7b2796de8a9",
    "hcp_id": "HCP_000048",
    "survey_date": "2025-01-25",
    "survey_type": "advisory_board",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 3,
    "awareness_score": 7,
    "favorability_score": 4,
    "previous_survey_id": "7cd655f1-f040-4505-ac4b-cf1a1835e927",
    "days_since_last_survey": 54,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2024-12-28"
      },
      {
        "type": "webinar",
        "date": "2025-01-08"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839093"
  },
  {
    "survey_id": "0a9291d2-b7a0-4658-8d2c-bd9c6ddf4dbe",
    "hcp_id": "HCP_000048",
    "survey_date": "2025-01-25",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -6,
    "awareness_score": 6,
    "favorability_score": 4,
    "previous_survey_id": "bc2d1659-e303-42dd-adb0-a7b2796de8a9",
    "days_since_last_survey": 83,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2024-12-26"
      },
      {
        "type": "webinar",
        "date": "2025-01-08"
      },
      {
        "type": "webinar",
        "date": "2025-01-17"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839112"
  },
  {
    "survey_id": "1a8719cf-778f-43b6-9ad8-bc48c0cf6037",
    "hcp_id": "HCP_000048",
    "survey_date": "2025-02-11",
    "survey_type": "advisory_board",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 5,
    "awareness_score": 4,
    "favorability_score": 7,
    "previous_survey_id": "0a9291d2-b7a0-4658-8d2c-bd9c6ddf4dbe",
    "days_since_last_survey": 90,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839134"
  },
  {
    "survey_id": "e896afe1-d2c9-4c12-9c12-13706cb117af",
    "hcp_id": "HCP_000048",
    "survey_date": "2025-02-11",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": -3,
    "awareness_score": 6,
    "favorability_score": 2,
    "previous_survey_id": "1a8719cf-778f-43b6-9ad8-bc48c0cf6037",
    "days_since_last_survey": 84,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-01-21"
      },
      {
        "type": "detail",
        "date": "2025-01-29"
      },
      {
        "type": "email",
        "date": "2025-01-14"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839153"
  },
  {
    "survey_id": "d2641740-1b5e-4900-9ff8-1d74fc84037c",
    "hcp_id": "HCP_000048",
    "survey_date": "2025-02-11",
    "survey_type": "advisory_board",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -2,
    "awareness_score": 6,
    "favorability_score": 4,
    "previous_survey_id": "e896afe1-d2c9-4c12-9c12-13706cb117af",
    "days_since_last_survey": 69,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-01-27"
      },
      {
        "type": "sample",
        "date": "2025-01-23"
      },
      {
        "type": "webinar",
        "date": "2025-01-31"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839173"
  },
  {
    "survey_id": "8d3c34e4-5ed4-44fd-b184-d348f10cd121",
    "hcp_id": "HCP_000048",
    "survey_date": "2025-03-30",
    "survey_type": "market_research",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 3,
    "intent_to_prescribe_change": 2,
    "awareness_score": 3,
    "favorability_score": 6,
    "previous_survey_id": "d2641740-1b5e-4900-9ff8-1d74fc84037c",
    "days_since_last_survey": 74,
    "interventions_since_last": [
      {
        "type": "webinar",
        "date": "2025-02-28"
      },
      {
        "type": "webinar",
        "date": "2025-03-06"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839203"
  },
  {
    "survey_id": "0354fe1e-34f8-4278-a7ee-5bcbe280e2bd",
    "hcp_id": "HCP_000048",
    "survey_date": "2025-03-30",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 3,
    "awareness_score": 3,
    "favorability_score": 4,
    "previous_survey_id": "8d3c34e4-5ed4-44fd-b184-d348f10cd121",
    "days_since_last_survey": 59,
    "interventions_since_last": [],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839227"
  },
  {
    "survey_id": "2f2a9ac1-0e28-464f-9dd2-c227460347ec",
    "hcp_id": "HCP_000048",
    "survey_date": "2025-03-30",
    "survey_type": "conference",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 5,
    "intent_to_prescribe_change": -1,
    "awareness_score": 6,
    "favorability_score": 4,
    "previous_survey_id": "0354fe1e-34f8-4278-a7ee-5bcbe280e2bd",
    "days_since_last_survey": 88,
    "interventions_since_last": [
      {
        "type": "detail",
        "date": "2025-03-16"
      },
      {
        "type": "email",
        "date": "2025-03-23"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839262"
  },
  {
    "survey_id": "ce3ec94e-1182-4c77-8cc8-500535faab87",
    "hcp_id": "HCP_000048",
    "survey_date": "2025-04-17",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -4,
    "awareness_score": 4,
    "favorability_score": 3,
    "previous_survey_id": "2f2a9ac1-0e28-464f-9dd2-c227460347ec",
    "days_since_last_survey": 74,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2025-03-24"
      },
      {
        "type": "email",
        "date": "2025-03-21"
      },
      {
        "type": "sample",
        "date": "2025-04-06"
      }
    ],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839308"
  },
  {
    "survey_id": "15d30930-0e98-4cf1-9fa9-ceb7b709141b",
    "hcp_id": "HCP_000048",
    "survey_date": "2025-04-17",
    "survey_type": "conference",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": 5,
    "awareness_score": 7,
    "favorability_score": 3,
    "previous_survey_id": "ce3ec94e-1182-4c77-8cc8-500535faab87",
    "days_since_last_survey": 69,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2025-04-15"
      },
      {
        "type": "email",
        "date": "2025-04-10"
      },
      {
        "type": "sample",
        "date": "2025-04-04"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839348"
  },
  {
    "survey_id": "3be7644a-7bfd-4226-90b0-781e262641f2",
    "hcp_id": "HCP_000048",
    "survey_date": "2025-04-17",
    "survey_type": "detail_followup",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 1,
    "intent_to_prescribe_change": -5,
    "awareness_score": 7,
    "favorability_score": 2,
    "previous_survey_id": "15d30930-0e98-4cf1-9fa9-ceb7b709141b",
    "days_since_last_survey": 85,
    "interventions_since_last": [],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839376"
  },
  {
    "survey_id": "09773f1d-4b0b-4eed-b365-913867b4ef98",
    "hcp_id": "HCP_000049",
    "survey_date": "2025-01-07",
    "survey_type": "conference",
    "brand": "Remibrutinib",
    "intent_to_prescribe_score": 4,
    "intent_to_prescribe_change": 0,
    "awareness_score": 4,
    "favorability_score": 6,
    "previous_survey_id": null,
    "days_since_last_survey": null,
    "interventions_since_last": [
      {
        "type": "email",
        "date": "2024-12-26"
      },
      {
        "type": "email",
        "date": "2025-01-01"
      },
      {
        "type": "detail",
        "date": "2024-12-18"
      }
    ],
    "survey_source": "Veeva",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839406"
  },
  {
    "survey_id": "b70b62cb-183e-45c5-86ba-63eb60da3756",
    "hcp_id": "HCP_000049",
    "survey_date": "2025-01-07",
    "survey_type": "detail_followup",
    "brand": "Fabhalta",
    "intent_to_prescribe_score": 7,
    "intent_to_prescribe_change": 3,
    "awareness_score": 3,
    "favorability_score": 4,
    "previous_survey_id": "09773f1d-4b0b-4eed-b365-913867b4ef98",
    "days_since_last_survey": 52,
    "interventions_since_last": [
      {
        "type": "sample",
        "date": "2024-12-15"
      }
    ],
    "survey_source": "Internal",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839421"
  },
  {
    "survey_id": "7ad5d853-6342-451a-b4bd-49a738d4cbf8",
    "hcp_id": "HCP_000049",
    "survey_date": "2025-01-07",
    "survey_type": "market_research",
    "brand": "Kisqali",
    "intent_to_prescribe_score": 6,
    "intent_to_prescribe_change": -1,
    "awareness_score": 4,
    "favorability_score": 7,
    "previous_survey_id": "b70b62cb-183e-45c5-86ba-63eb60da3756",
    "days_since_last_survey": 53,
    "interventions_since_last": [],
    "survey_source": "Third_Party",
    "response_quality_flag": true,
    "created_at": "2025-11-28T15:39:47.839434"
  }
]